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ABSTRACT 
Metallozymes are composed of a biomolecular scaffold harboring a metal complex. Such 
hybrid systems connect the “best” features of enzymatic (biomolecule) and homogenous 
(metal) catalysis. Chemogenetic optimization of metallozymes can lead to a wide range of 
applications in biotechnology and medicine. In this perspective, catalysis with a focus on 
broad reaction scopes, high activity and selectivity under mild reaction conditions as well as 
the development of artificial restriction enzymes for gene correction are the current topics 
of interest.  
 
The use of membrane proteins as proteinshell for metallozymes could broaden the range of 
applications due to their rigid and defined structure, structural integrity in e.g. organic 
solvents and at elevated temperatures as well as their easy modifiability. Still, researchers 
forgo the area of membrane proteins because the handling of the protein is highly 
challenging and requires lots of skillfulness. The constant presence of detergents mimicking 
the native protein environment is a drawback just as the expression and extraction in large 
scale with “good” quality. Crystal structures are rarely available and to set-up analytics is not 
easy.  
 
This thesis overcame the challenges of the development of a metallozyme based on a 
transmembrane β-barrel protein (FhuA) of E. coli. FhuA, made of 22 β-strands, was 
engineered and expression/extraction was optimized to make it a suitable scaffold. To gain 
catalytic activity, a ruthenium based cyclopentadienyl metal complex [Ru-Cp*] was coupled 
to the engineered FhuA. Analytical methods for FhuA metallozyme characterization were 
developed.  
 
In the first chapter, different FhuA variants were (re)engineered and molecular dynamic 
computer simulations were used to analyze the surrounding of the catalyst binding site.  
Following, for the developed variants, expression conditions in terms of media, temperature 
and time were optimized. Expression was scaled-up from 0.25 L flask expression to 10 L 
fermentation. Extraction was compared by protein solubilization with different detergents 
and harsh membrane dissolution with subsequent protein precipitation using organic 
solvents. The protein could be refolded by the polymer polyethylene-polyethylene 
glycol (PE-PEG). Regarding good yields and purity, protein solubilization with dodecyl-
maltoside followed by n-hexane-EtOH-SDS dissolution proved to be superior to other 
detergent and organic solvent based extraction methods, achieving up to 800 mg protein 
with a purity of 90 % from one liter extracted culture broth.  
 
 
 
Stability investigations in the organic cosolvents tetrahydrofuran (THF), ethanol (EtOH), 
chloroform/methanol (C/M) and dioxane were performed in the second chapter. Highest 
stability of selected variants was obtained in up to 40 vol% THF, 25 vol% dioxane, 10 vol% 
EtOH or C/M. Basic pH values are preferable over acidic ones and the variant FhuA 
Δ1-159_C556 (having least mutations referring to the wildtype DNA sequence) showed 
higher temperature stability than FhuA Δ1-159_C556_tev, possessing more mutation 
(melting point 74 °C vs. 55 °C).  
 
The third chapter focused on the development and characterization of the metallozyme 
based on FhuA-[Ru-Cp*]. The coupling efficiency was verified by cysteine titration and 
analyzed by MALDI-TOF-MS. Structural integrity after coupling was confirmed by CD 
spectrophotometry. 
 
In summary, in this thesis, for the first time, a large, highly hydrophobic engineered 
membrane protein was used as a biomolecular scaffold for the development of a 
metallozyme. Advantages of using FhuA are its high purity and tremendous stability in 
organic cosolvents, elevated temperatures and basic pH values. After assembly of the 
protein and the metal catalyst, the system was characterized and provides fundamentals for 
the use of other membrane proteins in metallozyme applications. Additionally on a short-
term basis, the herein designed protein including the developed methods is used for the 
generation of a “platform catalytic system”.   
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1 ABBREVIATIONS 
APS   ammonium persulfate 
BCA-assay  bicinchoninic acid-assay 
CD   circular dichroism 
CecEGFP cecropin A-EGFP 
C/M  chloroform/methanol 
CMC   critical micelle 
concentration 
CPME   cyclopentyl methyl ether 
csc  critical membrane 
solubilizing concentration of 
detergent 
C556  cysteine a position 556 
DDM   n-dodecyl-β-D-maltoside 
DHB  dihydroxy benzoic acid 
DM   n-decyl-β-D-maltoside 
DSC  differential scanning 
calorimetry 
EDTA   ethylenediaminetetraacetic 
acid 
FC-12   fos-choline 12 
FhuA   ferric hydroxamate uptake 
protein component A 
GAFF  general amber force field  
HCCA  α-cyanohydroxycinnamic 
acid 
HRP   horseradish peroxidase 
HEOS   2-hydroxyethyloctyl-
sulfoxide 
IMAGE-J Image processing and 
analysis in java 
IPTG   isopropyl-β-D-
thiogalactoside 
KPi buﬀer       potassium-phosphate buﬀer 
K556 lysine at position 556 
LB Luria-Bertani media 
LDAO  lauryldimethylamine-oxide 
MALDI-TOF-  Matrix-assisted laser 
     MS    desorption/ionization time 
of flight mass spectrometry 
M9 minimal media 
NVOC-Cl 6-nitroveratryloxycarbonyl 
chloride 
OD   optical density 
ompF  outer membrane protein F 
oPOE   octyl-polyoxyethylene 
PAGE   polyacrylamide gel 
electrophoresis 
PCR   polymerase chain reaction 
PED-database protein-engineering-design  
  database 
PE-PEG         polyethylene-
polyethyleneglycol 
PP  polypropylene 
PMSF   phenylmethanesulfonyl-
ﬂuoride 
RT  room temperature 
SA  sinapinic acid 
SDS   sodium dodecylsulfate 
SOB  super optimal broth media 
SOC  super optimal broth media 
with catabolite repression 
S556  serine at position 556 
TEMED         tetramethylethylendiamine 
TFE/C  trifluoroethanol/chloroform 
2-MeTHF          2 methyl-tetrahydrofurane 
TMB   3,3’,5,5’-tetramethyl-
benzidine 
TY tryptone yeast media 
YASARA Yet Another Scientific 
Artificial Reality Application 
 
Da  dalton 
g   gram 
h   hour 
kDa   kilodalton 
L   liter 
M   molar 
mg   milligram 
min   minute 
mdeg  millidegree 
mL   milliliter 
mm   millimeter 
mM   millimolar 
nm   nanometer 
rpm   revolutions per minute 
sec   second 
U   unit 
°C   degree celsius 
µg   microgram 
µL   microliter 
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2 INTRODUCTION 
The introduction is divided into three parts. The first part describes the state of the art of 
metallozymes, thereby concentrating on the advantages and disadvantages of choosing the 
one or other biological scaffold. The three types of anchoring strategies and the different 
possibilities for optimization of the metallozyme will be discussed. Selected catalytic 
highlights as well as the state of the art of metallozymes are presented. The second part 
gives general and specific information on the biomolecular scaffold and the metal complex. 
Additionally the coupling strategy of the metal to the protein are described, including Yet 
Another Scientific Artificial Reality Application (Yasara) analysis of possible conformations of 
the metal within the protein backbone. Part three outlines the thesis objective. 
 
2.1 State of the art: metallozymes 
Metallozymes consist of two different units: a metal complex which is incorporated into a 
host biomolecule either composed of protein or DNA [1]. The arising hybrid catalyst 
connects the best features of homogeneous (metal) and enzymatic (biomolecule) 
catalysis [2, 3]. Advantages of homogeneous catalysis are the broad reaction repertoire, the 
large (but mainly apolar) substrate scope and the compatibility with almost any metal. 
Enzymatic catalysis is characterized by their impressive catalytic activity under mild reaction 
conditions and their remarkable selectivity. The substrate scope is rather limited when 
compared to homogenous catalysts [3]. Combining the best features of two distinct worlds 
has a big potential for applications in biotechnology and medicine, especially because each 
unit can be optimized separately. An additional advantage of catalysis performed with 
biomolecules over traditional metal catalysis is that ligands do not need to be chiral. Chirality 
is given by the biomolecular scaffold that provides the 2nd coordination sphere [1, 2]. This 
results in less effort for the development of the catalytic moiety.  
 
Selection of a DNA or protein scaffold  
In order to select the hybrid scaffold, one firstly has to decide if it is advantageous to use a 
protein- or DNA scaffold. The decision strongly depends on the reaction that will be 
performed. For example oxidative reactions are easier to run with a protein-based scaffold 
because DNA scaffolds are susceptible towards strand breakage. Considerations towards 
pH- and temperature stability as well as organic cosolvent resistance [2] have to be made in 
the same way as checking expression-/extraction level of the biomolecule and the thereby 
associated intensity of labor. It is obvious that cost-effective biomolecules are favorable.   
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Besides that, decisions have to be made if the catalyst should attach to the scaffold via an 
existing active site which, if necessary, can be reengineered to optimize performances, or if a 
new active site needs to be reengineered. A new active site on the one hand side expands 
the number of scaffolds that can be used but on the other hand side, addition of a new 
active site might affect structure and stability of the scaffold. In the worst case, stabilizing 
interactions might be broken or new ones are generated that affect the stability of the 
protein [2].  
Further questions are the required size of the binding-cavity. Is it big enough for both, the 
metal complex and the substrate?  
Besides modifying native proteins, it is also possible to design de novo protein scaffolds [4]. 
So far, only a few types such as α-helical bundles were designed from scratch. Folding, 
stability and unforeseeable interactions are some of the key words to think about before 
designing de novo metallozymes. In comparison, plenty of proteins exist in nature. These 
proteins are often well characterized. One has to reconsider whether it is not easier to take 
one of the 80000 proteins described in the Protein Data Bank, as a starting point for hybrid 
systems. Just three years ago, Lu et al. [4] stated that in nature around 600 types of protein 
with diverse function are based on β-barrel proteins. Oxidation, reduction and hydrolysis are 
just some of the reactions performed with these proteins. Simple “copy-pasting” of an 
existing mechanism and, if necessary, adaption to the requirements needed for the specific 
application, might be easier than de novo design of a metallozyme.  
 
Anchoring strategies 
To localize the metal device in/to the biomolecular scaffold, noncovalent anchoring and 
covalent anchoring approaches can be used. Noncovalent anchoring can be subdivided into 
supramolecular and dative anchoring (Figure 1).bbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbbb 
 
Figure 1: Anchoring strategies for metallozymes: a) supramolecular, b) dative and c) covalent. 
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The attachment of the catalyst to the protein via supramolecular anchoring is very strong 
and highly specific. It is based on noncovalent interactions of the scaffold with another 
molecule. One of the best known examples of supramolecular anchoring are 
(strept)avidin/biotin (key-lock principle), DNA-based systems (intercalation of aromatic 
moieties with the DNA-double helix) and antibodies (specific recognition of the metal 
complex). The self-assembly of these complexes allows fast and straight forward 
optimization. Precaution must be taken that the supramolecular binding strengths and 
selectivity of the metal catalyst to bind to the “desired” protein binding site are stronger 
than the strengths of the metal catalyst to bind at an unspecific binding site of the scaffold. 
Reactions performed with hybrid catalysts anchored via the supramolecular approach are 
e.g. ketone reduction and alcohol oxidation [1]. 
Dative anchoring relies on coordinative bonds between the metal ion and the biomolecular 
scaffold. This anchoring strategy was initially developed by the Kaiser group [5]. The chosen 
biomolecular scaffold was a carboxypeptidase A. Substitution of Zn2+ at its active site by Cu2+ 
enabled the enzyme to perform oxidase activity. Concerning dative anchoring, several 
studies indicated the importance of tyrosines which interact with metal ions. For example 
anchoring of heme to human serum albumin or Mn-corrole and Cu-phthalocyanine to bovine 
serum albumin occurred via tyrosines [1]. Advantage of using dative anchoring is the exact 
positioning of the metal within the scaffold. Performed reactions include sulfoxidation and 
Diels-Alder cycloaddition [6, 7].  
The covalent approach was also initially reported by researchers around E. T. Kaiser [8, 9]. 
The principle relies on the binding of a metal complex to a ligand that covalently attaches to 
a predetermined site of the selected scaffold. For their studies, papain was converted into an 
oxidoreductase by covalent modification of the sulfhydryl group of Cys25 with flavins. 
Besides covalent linkage via cysteine at the active site of subtilisin, functional groups of 
serine (from a lipase) and lysine (antibody 38C2) were also used for coupling. The performed 
reactions were for example reduction, hydrolysis, epoxidation and hydrogenation [3].  
 
Optimization of the metallozyme 
As mentioned above, a metallozyme consists of two distinct units, the metal and the 
biomolecular scaffold. The metallozyme can be tailored for desired properties by optimizing 
the metal catalyst and reengineering of the biomolecular scaffold. The approach to optimize 
both parts simultaneously is called chemogenetic, meaning chemically modification of the 
metal catalyst and genetic modification of the biomolecular scaffold.  
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The catalytic features can be improved by electronic or steric modifications of the ligand 
sphere. Reactivity can be optimized by exchanging leaving groups. Replacement of NH3, CN 
and CO by “easier leaving groups” such as Br, Cl, OH and phosphine can contribute to a 
higher reactivity of the catalyst. Unfortunately, this goes often along with decreasing 
stability of the system. Addition of sterically demanding ligands may change product 
selectivity. In order to find the “best” substitutes for the desired reaction, physical- and 
structural models are analyzed.  
Optimization of the biomolecular scaffold can be achieved by rational design, directed 
evolution or rational design in combination with directed evolution. In terms of rational 
design, computer based models are used to find the best binding site for the catalyst in a 
scaffold [2]. Scaffold optimization by directed evolution involves the following steps: 
introduction of the mutation to the encoded gene of the protein of interest to create gene 
diversity (e.g. error-prone PCR), screening for variants with improved activity, selectivity, 
stability etc. The improved mutants may be recombined and used as template for the next 
round of mutagenesis until the desired improvement is achieved. Advantage of the directed 
evolution approach is the possibility to detect mutations located far away from the active 
site that at the same time influence the catalytic activity. However, mutant libraries increase 
in size and high throughput screening technologies would be necessary in order to screen for 
the best metallozymes. For optimization, supramolecular anchoring techniques are 
preferential to researchers due to strong and highly specific linkage of the metal complex to 
the protein [2, 10].  
To limit the library size, the number of experiments required and to increase the quality of 
the library, site directed mutagenesis on regions close to the active center can be 
performed. This approach is called semirational design.  
In general, optimization of the biomolecular scaffold is carried out in successive rounds. One 
parameter is modified after the other. This kind of optimization does not take into account 
cooperative effects of the biomolecule, linker and (if available) the spacer, but it limits the 
screening efforts [11]. It was found out that chemical modification of spacers (variation of 
length and rigidity) highly affects the performance of the hybrid catalyst while genetic 
engineering was observed to be mainly important for fine-tuning of the hybrid catalyst. 
Therefore, it is sufficient to screen small libraries that were chemically modified, while 
genetically modified libraries need to be screened in larger extents in order to find the 
“best” mutant [12].  
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Selected catalytic highlights 
The first hybrid systems were evolved in the late 1970s. For another 20 years, the field 
remained almost unexplored but, within the last years, the hybrid “black box model” turned 
into an emerging research area. Interdisciplinary approaches are followed to reach “best” 
activity and selectivity of the catalytic reaction.   
One of the first success stories was an avidin scaffold that bound (supramolecular) to biotin, 
while biotin was coupled to a rhodium phosphine complex. Enantioselective hydrogenation 
gave 41 % ee (S) [13]. An increased enantiomeric excess of 96 % (R) for hydrogenation of 
acetamidoacrylic acid was obtained using streptavidin and chemogenetic approaches on the 
ligand and on residues close to the binding site [14, 15]. Bovine carbonic anhydrase was used 
for stereoselective hydrogenation of olefins. Active site replacement of Zn2+ by Rh increased 
Z-stilbene stereoselectivity up to 20 times [16]. Ru linked to biotin via an aminosulfonamide 
ligand which was bound to streptavidin was used for transfer hydrogenation of 
acetophenone. Enantiomeric phenylethanols were obtained. After genetic evolution of S112 
by phenylalanine or tyrosine, 97 % ee (R) were achieved [17].  
Tremendous developments of metallozymes were made with oxidation reactions performed 
by Mn-salen complexes. Sulfoxidation of apo-myoglobin, which was noncovalently anchored 
to Mn-salen, yielded 32 % ee for the S enantiomer. Covalent anchoring via a dual point 
attachment strategy led to 51 % ee of the R enantiomer. Changing the Mn-salen binding side 
on the protein surface, ee-values were increased to 60 %. By altering pH values and the 
anchoring strategy (supramolecular), the ee-value reached 67 % [2]. Similar results were 
obtained with for the S enantiomer (66 % ee). In this case, vanadate was bound to a 
phytase [18]. Applying a similar catalyst to streptavidin, even 96 % ee could be reached [19].  
The biotin/streptavidin system in combination with a PdII-complex yielded 93 % ee in allylic 
alkylation of 1,3-diphenylallylacetate. In order to reach this ee-value, the following 
optimization steps were performed: surfactants were used and chemogenetic modifications 
on the spacer (located between biotin and the metal complex) as well as on the 
biomolecule [20].  
Another interesting type of reactions are C-C bond forming reactions. A DNA intercalating 
linker was attached to a spacer that was bound to an achiral CuII complex. A Diels-Alder 
reaction of azochalcone with cyclopentadiene was performed. Chemogenetic optimizations 
lead to > 99 % ee of the endo isomer [21]. The same reaction was also performed with 
bovine serum albumin as a biomolecular host. In this case, 98 % ee were obtained by a CuII 
catalyzed Diels-Alder reaction, applying azochalcone in combination with 
cyclopentadiene [22]. 
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Current status of metallozymes 
The variety of catalytically performed reactions by means of metallozymes is broad and is 
rapidly developing within the last few years. Chemogenetic optimization is the key factor to 
create chemical and genetic diversity. It quickly expanded the range of applications and the 
use of challenging substrates. Organic solvent tolerance of the biomolecular scaffold was a 
great step forward to obtain better catalyst solubility and higher efficiency of the reaction 
rate. However, the reactions are predominantly performed in water which contributes to 
good environmental compatibility. Costs were decreased by catalyst recycling. For large 
biotechnological applications some aspects remain to be tackled: the preparative scale 
challenge has to be overcome and the costs for production of the metallozyme have to be 
reduced. The optimization potential exists and new screening systems as well as protein 
scaffold engineering, fuel the development of research in metallozymes.  
 
2.2 Biomolecular scaffold and metal complex 
Ferric hydroxamate uptake protein component A (FhuA)  
The ferric hydroxamate uptake protein component A (FhuA) was chosen as a scaffold for the 
development of a metallozyme. FhuA, with a size of 78.9 kDa [23], belongs to the outer 
membrane transporters of Escherichia coli. With 1000 copies per cell it is regarded as a 
minor protein of E. coli. Its physical function is the uptake of ferrichrome [24]. Energy for the 
translocation of ferrichrome is provided by the proton-motive of the cytoplasmic membrane. 
Responsible for the energy transfer to the outer membrane is the cytoplasmic-membrane 
located Ton protein complex. The complex consists of TonB, ExbB and ExbD [25, 26]. Besides 
ferrichrome transport, FhuA serves as a receptor for phage T1, T5 and Ф80 as well as for the 
ferrichrome structurally analogues antibiotic colicin M [27]. Initially, at the same time, FhuA 
was crystallized in free and ferrichrome-bound state by Locher et al. [28] and 
Ferguson et al. [29]. The latter showed besides the crystal structure of FhuA, a 
lipopolysaccharide bound to the protein.  FhuA is monomeric, composed of a hydrophobic 
β-barrel structure (C-terminal, residue 161-723) which is obstructed by a plug, also termed 
as cork domain (N-terminal, residue 1-160). With a barrel height of 69 Å and an elliptical 
cross section of 39-46 Å, FhuA is larger than any barrel forming porin of gram-negative 
bacteria. The barrel itself is built of 22 antiparallel transmembrane β-strands. The 
transmembrane β-strands exhibit 57.1 % of the barrel and are built of 7-25 amino acids 
(average length: 14.4 amino acids). Six amino acids is the minimum required to span the 
membrane bilayer. The membrane embedded surface mainly consists of hydrophobic 
residues (AVILM, 45.4 %), roughly one third aromatic residues (FYW) and only 6 % charged 
residues (EDHKR) [30]. Aromatic residues are predominantly placed in two belts around the 
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upper and lower part of the protein [28]. The side chains of the belt forming amino acids 
point towards the polar head group of the lipopolysaccharide. It is assumed that by means of 
this interaction, the protein is anchored to the membrane. Connection of the strands is 
accomplished by loops. The periplasmic turns are short (on average 5 amino acids), while 
surface-located loops are longer (on average 17 amino acids) [30]. The longest loop, L4, 
raises around 35 Å above the membrane surface while it can narrow the channel entrance to 
roughly half the area of the total cross section [28]. According to Ferguson et al. [29], the 
cork domain consists of a mixed, four-stranded β-sheet. Locher et al. [28] reported five 
α-helices and six β-strands. The plug (also described as “cork”) is connected to the interior of 
the barrel via 60 hydrogen bonds and nine salt bridges. This leads to a blocked channel, 
suggesting no diffusion of small molecules through FhuA [28, 29].  
 
Initial studies of FhuA investigated the interrelation between the two domains as well as the 
characteristics of the protein as a transporter/receptor for ferrichrome, phages and 
antibiotics. In this regard, also channel conductance experiments were of broad 
interest [31-34]. After performance of these fundamental experiments, first ideas towards 
possible application of FhuA in biotechnology and medicine emerged. Establishment of 
techniques to incorporate the protein in polymersomes and liposomes helped to understand 
channel dynamics and to construct tunable release systems [35-41]. The range of 
applications can be expanded due to advantages of FhuA (like size, robustness and easy 
modifiability) over other proteins. Therefore FhuA is a attractive scaffold for metallozymes. 
So far, no study was reported on the use of a hydrophobic barrel protein as scaffold for 
metallozyme development. The laborious expression/extraction of membrane proteins in 
contrast to other proteins already discourages to work with this kind of proteins. However, 
the structure and characteristics of barrel proteins can definitively contribute to enlarge the 
field of metallozymes. Reasons to choose FhuA for this purpose are described in the next 
section.  
 
The large channel diameter (20-25 Å) of FhuA provides sufficient space to harbor the metal 
catalyst. Availability of the crystal structure [28, 29], which is often not available for 
membrane proteins, and realized molecular studies [35] (to find the best coupling position), 
are a good starting point to choose FhuA as the biomolecular scaffold for metallozyme 
development. FhuA can be easily expressed with the well understood E. coli expression 
system. Expression in inclusion bodies is an alternative to membrane expression. This 
approach can be used to overcome limitations in membrane-targeted expression [42, 43]. 
Successful large scale fermentation (10 L) pointed out that industrial scale production of the 
FhuA protein is possible. Other surveys showed that FhuA can easily be mutagenized, 
regardless of single amino acid exchanges or deletion/addition of several amino 
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acids [32, 34, 36, 40, 44, 45]. It is assumed that engineering of the protein pores can be used 
to discriminate between the substrates based on their shape and size. The channel like 
structure of FhuA which is based on β-strands, imparts the protein stability, rigidity and a 
defined structure. These characteristics were further investigated in stability studies by 
means of organic cosolvents [46] and temperature [31]. Additionally, stability studies with a 
trypsin protease and denaturants were conducted, communicating that mutagenesis of the 
protein influences its stability [31].  
 
All these studies demonstrate that FhuA is a good choice as biological scaffold for 
metallozymes. In order to use FhuA as a scaffold, several genetic optimization steps were 
required. Finally, the protein variant named FhuA Δ1-159_C556_tev was developed and 
coupled to a metal catalyst. A detailed description of the FhuA reengineering is presented in 
chapter A.  
 
[Ru-Cp*] metal complex  
The choice of the metal was restricted to the requirements of the biological entity whereas 
the biggest challenge was to select a metal that does not react with water nor is destroyed 
by water. Furthermore stability of the metal towards moisture and air is advantageous. 
Ruthenium meets the aforementioned requirements and it is already widely examined in 
organometallic transformations, for example in cyclopropanation [47, 48], Diels-Alder 
reaction [49], Alder-ene reaction [50, 51], C-C [52] and alkyne coupling reaction [53]. 
Additionally, ruthenium is highly reactive and shows a redox potential from -2 to +8. In 
contrary to other transition metals ruthenium is relatively cheap. Besides that a large 
number of organic ligands can be metallated by ruthenium to form stable complexes.  
Cp* was selected as one of the ligands for ruthenium because of “strong bonds” between 
Cp* and ruthenium that should allow the synthesis of a water stable complex. Easy synthesis 
of [Ru-Cp*] in good yields is furthermore advantageous. 
The choice of the CO ligand was simply accompanied by the need to functionalize the 
Cp*-ring during synthesis in order to fix the linker. Functionalization was performed as 
described by Maitlis et al. [54-57]. A stream of CO gas was applied, which leads to a 
nucleophilic attack of the chloride on one of the methyl groups of the Cp*-ring. Exchange of 
chloride by an alcohol led to a functionalized Cp*-ring. The rising bonds between CO and 
ruthenium are very robust and it was assumed that they survive under the harsh coupling 
conditions.  
Chloride as a ligand remains from the starting compound RuCl3. Chloride is regarded as an 
“easier leaving group” and therefore it should activate the catalyst during the successive 
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organic transformation. Additionally, to further activate the catalyst or to change its 
property towards the solvent (increased water solubility), the ligand may be exchanged by 
less coordination ligands as for example –PF6 and 
–BF4.  
The catalyst design towards Lewis acid activity should allow to perform Diels-Alder (or 
Alder ene) reactions. Characteristic for these types of reactions are the use of water as a 
solvent, catalytic performance at room temperature, no need of coadditive addition and 
insensitivity towards pH value variations. These characteristics are in agreement with the 
needs of the biological scaffold.  
Diels-Alder reactions can be performed in an asymmetric manner. The chiral environment of 
the protein backbone is expected to tune the selectivity towards the desired product. 
Possible endo- and exoproduct formation (norbornene) by a Diels-Alder catalyzed reaction 
of enone with cyclopentadiene in presence of FhuA Δ1-159_C556_tev-[Ru-Cp*] are 
described in Figure 2.  
 
 
Figure 2: Lewis acid catalyzed Diels-Alder reaction of enone with cyclopentadiene in presence of 
[Ru-Cp*] coupled to FhuA Δ1-159_C556_tev result in an endo- or exoproduct of norbornene.  
 
2.3 Thesis objective 
The objective of this thesis was to establish a proof of concept by using FhuA, as one of the 
largest highly hydrophobic β-barrel proteins of E. coli, as scaffold for metallozymes. A 
Ru-based metal complex was chosen to be attached via covalent anchoring to a cysteine 
located in the inside of the barrel lumen.  
The preceding introduction part introduced the research in the field of metallozymes and 
gave general as well as specific information on the FhuA protein and the Ru-based metal 
complex.  The subsequent part described the main analytical methods applied in this work: 
 endoproduct             exoproduct 
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circular dichroism (CD), matrix-assisted laser desorption/ionization time of flight mass 
spectrometry (MALDI-TOF-MS) and dynamic scanning calorimetry (DSC).  
The experimental part was subdivided into three chapters (A, B, C).  Chapter A described the 
engineering, expression, extraction and purification of five different FhuA variants. Chapter B 
investigated stability of FhuA variants in presence of organic cosolvents, pH and 
temperature. The last chapter dealt with the coupling of the metal complex to FhuA and 
analytic characterization of the arising metallozyme, including CD measurements, cysteine 
titration and MALDI-analysis.  
The doctorial thesis is summarized in part five.                           
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3 ANALYTICAL METHODS 
General methods used to analyze the binding of the metal to the biomolecular scaffold are 
electrospray ionization (ESI) or rather MALDI [58, 59], fluorescence quenching [58] and UV 
spectroscopy [58]. Structural changes of the protein upon binding are determined by CD [58] 
while educt/producs are characterized by HPLC [17] and UV [17]. An overview of the 
structural integrity of the protein can be obtained by DSC. The most important methods that 
were used in this work are explained below.   
 
3.1 Circular dichroism (CD) 
Since the 1960s, CD is a powerful tool to examine the secondary structure composition of 
proteins, the tertiary structure fingerprint, the integrity of cofactor binding site as well as 
conformational changes in proteins [60]. The measurements rely on the differential 
absorption of left- and right circularly polarized light by chromophores. For CD 
measurements, the chromophores of interest include the peptide bond absorption 
(≤ 240 nm), aromatic side chains (260-320 nm), disulphide bonds (around 260 nm) and non-
protein cofactors (e.g. haem groups and chlorophyll).  
To analyze the secondary structure of proteins, absorption of the peptide bond n  π* 
(around 220 nm) and π  π* (around 190 nm) transitions are of interest. They are 
influenced by the geometries of the polypeptide backbone (Ф- and ψ-angles) (Figure 3). By 
means of the obtained spectra, the three general secondary structure compositions, α, β and 
irregular structure, can be distinguished (Figure 4). It is important to mention that the 
spectrum is a sum of the structures of the whole protein. It is not possible to distinguish 
between the different structures of certain regions within the protein [61, 62]. In 
conjunction with secondary structure prediction algorithms, the value of information by CD 
is strongly enhanced since the amount of the structural elements is given. Widely used 
algorithms for this purpose include CONTIN [63], SELCON (self-consistent) [64], VARSLC 
(variable selection) [65], k2d [66] and CDSSTR [67]. Online tools, e.g. DICHROWEB [68, 69] 
allow analysis of the data by various algorithms. The process of identifying the percentage of 
secondary structures from a recorded spectrum is termed deconvolution.  
Figure 3: Portion of a polypeptide showing
angles Ф and ψ. (http://openlearn.open.ac.uk/
 
Figure 4: CD spectra of a protein which 
(http://mach7.bluehill.com/proteinc/cd/cdspec.html
 
CD measurements of membrane proteins
Structural analysis of highly hydrophobic m
[46, 62, 70, 71]. First of all, deeply in membrane embedded proteins are difficult to prepare 
in good purity and soluble form. 
with the use of detergents that
of the solvent [70]. Furthermore high signal/noise ratios of detergents, especially below 200 
nm were described. This also might affect subsequent data analysis 
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 possible rotation at Cα-N and Cα-C, defined by the torsion 
, 22.03.12, with slight modifications
 
is composed of a α-helical, β-sheet or 
, 21.03.2012, with slight modifications
 
embrane proteins in CD
Solubilization of membrane proteins is in general associated 
 can lead to wavelength shifts due to changes in the polarity 
[62
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irregular structure. 
). 
 is challenging 
, 72]. The various 
3 ANALYTICAL METHODS 
15 
 
types of β-structures (e.g. barrels, sheets, propellers, β-helices) may result in variable peak 
positions. The same is due for membrane debris, causing optical artifacts by scattering light. 
Last but not least, the negative peak of the β-spectrum is about one-third of the intensity of 
the negative peak of an α-helical structure and therefore can simply be dwarfed [73]. 
Taken into account the aforementioned difficulties to record a CD signal of a membrane 
protein, deconvolution of recorded membrane protein spectra is also challenging. This is 
simply based on the fact that membrane proteins make up only a small proportion of known 
protein structures because it is demanding to obtain their crystalline structure due to the 
lack of a “native-like” environment for crystallization. In order to get the correct crystal 
structure, it is necessary to find a detergent that exactly mimics the membrane environment 
of the investigated protein. If a “wrong” detergent was chosen, the protein structure does 
not fold into its natural conformation, hence the analyzed data interpretation is false. Up to 
date, scientists differ in their conception if the secondary structure of membrane proteins 
can be analyzed by the existing algorithms, which are mainly based on soluble proteins. 
Wallace et al. [70] stated that for all examined proteins, reference databases derived from 
soluble proteins do not give reliable results if applied to membrane proteins. The support 
was given by the neglected analysis of spectral differences of membrane towards soluble 
proteins. Reasons are wavelength shifts, initiated by the use of different solvents and higher 
variability of β-strand structures. In contrast to these findings, Park et al. [74] examined 
spectral peak variations of 30 membrane proteins and ascertained that the variations were 
similar to soluble proteins. Besides this disagreement, both scientists confirmed the 
necessity of a wide range of secondary structures in the reference set. Regardless of the 
analysis method used, a huge reference set with plenty of data will lead to more accurate 
results. Finding an efficient deconvolution method becomes easier if information about the 
content of each structural element (based on crystal structures) are accessible. If for 
example the protein purity of the sample to be measured is good, no CD disturbing solvents 
were supplemented and the recorded spectra looks similar to a β-sheet structure, but the 
method used for deconvolution displays the presence of an almost pure α-helical protein, 
the use of the applied method has to be reconsidered. Analysis in a “black box” manner can 
produce unreliable or even wrong conclusions. 
Insights into the folding state of FhuA by CD were published in 1996 for the first time [75]. 
The structures of FhuA WT upon ferrichrome binding and without binding were measured. 
Furthermore different detergents were tested: lauryldimethylamine-oxide (LDAO), 
octylglucoside and octylpolyoxyethylene. Estimation of the relative amount of secondary 
structure was determined by VARSLC1, yielding 14 % α and 32 % β structure. In recent 
years (2010-2011), engineered FhuA deletion variants; FhuA Δ1-159_K556 for photo-
cleavable labeling with 6-nitroveratryloxycarbonyl chloride (NVOC-Cl) [35], FhuA Δ1-159_ext 
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(with elongated hydrophobic region) [40] and FhuA Δ1-159_exp (with expanded diameter) 
[44] were analyzed by CD, too. Detergents surrounding the protein were oPOE or HEOS. 
Additionally, CD spectra of FhuA Δ1-159 expressed in inclusion bodies but refolded with the 
detergent PE-PEG were recorded [43]. The latest studies depict the structural integrity of 
FhuA and FhuA Δ1-159 upon addition of organic cosolvents [46] or upon extraction with the 
organic solvents 2-methyltetrahydrofuran (2-MeTHF) and cyclopentylmethylether (CPME) 
(here: FhuA Δ1-159_C556) [76]. These examples nicely show that FhuA variants can be 
analyzed by CD.   
 
3.2 Differential scanning calorimetry (DSC) 
DSC provides insights in structure, folding and stability of proteins. Effects of mutation, 
buffer, pH and additives can be detected in the same way as stability contribution of 
individual domains or biomolecular interactions, e.g. interactions of ligand-protein or DNA-
protein. The analysis is based on heat changes associated with thermal denaturation of the 
biomolecule. Comparisons are made by the rate of heat flow to the biomolecule and to an 
inert material which are heated or cooled at the same rate. Structural changes of the sample 
come along with changes in the heat flow, resulting in a peak (Figure 5). Measuring a 
protein, this peak correlates with the unfolding of the molecule. Unfolding is typically 
endothermic. The Tm (midpoint) value, which can be obtained by DSC, reveals the 
temperature when 50 % of the protein is in its native conformation and 50 % are unfolded. 
Higher Tm values are related to higher protein stability, the protein is less susceptible to 
unfolding and denaturation at lower temperatures. The area under the peak is correlated 
with the content of ordered secondary structure of the protein and termed as ΔH°. 
Disruption of hydrogen bonds (endothermic) and break-up of hydrophobic interactions or 
protein aggregation (exothermic) both contribute to the net value of ΔH° [77].  
The wide range of application and the high accuracy of the displayed thermodynamic 
parameters increase the attractivity of DSC analysis tremendously. Besides that only a few 
micrograms of protein are required for the measurements.  
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Figure 5: Set-up of a dynamic scanning calorimetry (DSC) instrument.  
 
First DSC stability studies to characterize the unfolding process of FhuA WT and a deletion 
variant (FhuA Δ021-128) in presence of ferri-ferrichrome were performed in 2001 by 
Bonhiver et al. [31]. FhuA WT displayed two peaks at T1 65 °C and T2 74.4 °C. Presence of 
ferri-ferrichrome shifted T1 up to 71.4 °C while T2 remained unchanged. FhuA Δ021-128 
displayed only a single broader peak at 61.6 °C, nevertheless ferri-ferrichrome was present 
or absent. The recorded data confirmed a) the presence of two separately folding domains 
and b) that the cork domain contributes to thermal stability. The latter was also expected 
from crystallographic data [28]. 
 
3.3 Matrix-assisted laser desorption/ionization time of flight mass spectrometry 
(MALDI-TOF-MS) 
Mass analysis of proteins, sugars and polymers can be performed by MALDI analysis. 
Additionally, organometallic complexes [78, 79] and membrane proteins [80, 81] have been 
successfully investigated.  Strengths of the MALDI technique are the high throughput (within 
minutes), its high sensitivity (femtomole range) and measurement accuracy (0.01 %) that 
even allows to detect post-translational modifications. Advantageous is furthermore the 
tolerance towards contaminants such as salts and buffers [80, 82].  
The MALDI-TOF instrument consists of three parts, the ion source (MALDI part), the mass 
analyzer (TOF part) and the detector. Short laser pulses are shot to the sample that is 
cocrystallized with a matrix. The energy is absorbed by the matrix and is used to volatilize 
the sample while protons are transferred from the matrix to the biomolecule. The ionized 
sample enters the flight tube (TOF part) and based on the flight time, the mass-to-charge 
(m/z) ratio of the individual ions is measured.  Constant energy pulses lead to a longer flight 
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time of peptides with high mass. Finally, at the end of the flight tube, the peptides reach the 
detector. Each time a pulse is generated, the ionized sample flies through the flight tube and 
the signal is detected. The recorded mass spectra are a sum of spectra recorded for several 
pulses of ions. In case of mass analysis of small peptides, MALDI instruments possess a 
reflectron. The reflectron compromises small spreads of time and kinetic energy during 
ionization. A schematic representation of MALDI-TOF mass spectroscopy with reflectron is 
presented in Figure 6.  
 
Figure 6: A schematic representation of MALDI-TOF mass spectroscopy with reflectron. Analyte 
molecules are cocrystallized in the matrix. A short laser pulse ionizes the sample, while small 
molecules fly faster through the flight tube. The direction of flight is deflected at the reflectron. At 
the end of the flight tube, the signal is detected by the detector. [83] (with slight modifications). 
Various methods are available to prepare protein samples for MALDI. For big proteins or 
those who do not fly (e.g. due to hydrophobicity) it is very common to improve 
fragmentation efficiency by chemical or enzymatic digestion of the protein. For chemical 
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digestion, hydroxylamine or bromcyan are widely used. In the first case, the protein is cut 
behind aspartic- and glutamic acid. In the second case, restriction occurs behind methionin. 
For enzymatic digestion, trypsin is the most commonly applied enzyme. It digests the protein 
behind arginine and lysine. AspN, GlucC, LysC or chymotrypsin are other enzymes with 
specific or unspecific restriction patterns that can be used. Protein digestion can either be 
done in-solution or in-gel. In-gel digestion is preferably used for proteins with lots of 
impurities like salts and buffer components [84].  
To mix the sample with the matrix, the most common method is dried droplet. Thereby, 
sample and matrix solution are pre-mixed, applied on the sample plate and dried under air. 
Other sample deposition techniques like thin-layer and sandwich are also promising [85, 86]. 
For the thin-layer technique the thin layer substrate solution is spread on the sample plate. 
This serves as a seeding ground for cocrystallization of analyte/matrix [87]. For the sandwich 
method the matrix is deposited on the target and dried. Subsequently, the analyte/matrix 
mixture is added on top of the dried matrix layer [88].  
The matrix itself needs to absorb energy at a specific laser wavelength. Organic compound 
like sinapinic acid (SA), dihydroxy benzoic acid (DHB) or α-cyanohydroxycinnamic acid (HCCA) 
are applied for this purpose. SA is commonly used for proteins and peptides, DHB 
additionally for glycoconjugates and HCCA for peptides, especially hydrophobic ones [86]. 
The choice of the method and the matrix material depends mainly on the origin of the 
sample which should be analyzed as well as on the sizes of the expected peptide 
fragments [85].  
Before starting analysis of the protein sample, the instrument is calibrated by an internal or 
external mass calibration. If the sample was trypsin digested, the auto digested trypsin 
peptides can be used as an internal calibration. For external calibration, a standard protein 
sample, e.g. lactoglobulin, can be applied. Measuring the protein sample, slight variations of 
the expected and the measured mass should be accepted. They easily can be caused by the 
different composition of the residues [89].  
Notorious problems of membrane protein mass analysis is the low abundance of these 
proteins, their detergent “jacket”, easy self-aggregation due to their hydrophobic nature and 
a limited number of trypsin cleavage sites  [80, 81].  But within the last years, lots of work 
has been done to simplify mass analysis of membrane proteins. Higher signal-noise ratios 
were obtained from on-chip preparation [81], Invitrogen developed a commercially available 
surfactant to remove detergents and salts, without interfering with matrix crystals or the 
ionization of the protein sample [90]. Additionally, studies considering the solubilization of 
membrane proteins in nonionic detergents were published. Detergent concentration was 
found to be best above the critical micelle concentration (CMC), while best spectra were 
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obtained using 4HCCA with ultrathin-layer sample preparation method [91]. Nevertheless, 
due to plenty approaches published, describing how to tackle the difficulties with mass 
analysis of membrane proteins, it remains a challenge to choose the best settings for the 
respective protein. For FhuA, up to date, no mass analyses were performed.   
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4 EXPERIMENTAL CHAPTER A-C 
All chemicals were of analytical grade or higher quality, purchased from Sigma-Aldrich/ Fluka 
Chemie (Taufkirchen, Germany), Applichem (Darmstadt, Germany), Merck (Darmstadt, 
Germany) or Carl Roth (Karlsruhe, Germany). Detailed information about supplier and purity 
can be obtained from section 11.4., list of chemicals and media.  
Protocols developed for the expression, extraction, purification and analytical performances 
are given in full length in section 11.2., protocols. Furthermore they are deposited in the 
protein-engineering-design database (PED-database) of the Schwaneberg group (Institute of 
Biotechnology, RWTH Aachen University, Aachen, Germany). Further information on 
fhuA-variant sequences can be obtained on demand from the Schwaneberg group.  
 
Chapter A                                                                                                                            
ENGINEERING, EXPRESSION, EXTRACTION, PURIFICATION  
 
1. Introduction 
The plasmid of the parent membrane protein FhuA was received as a gift from Prof. V. 
Braun [92]. Based on this variant, a cork-domain-deleted protein, FhuA Δ1-159 was 
engineered by N. Madhaven [38]. FhuA and FhuA Δ1-159 were selected as the starting 
variants for the development of the metallozyme. Güven et al. [36] substituted six lysine 
residues in two subsets (1. either one lysine was present and the other five lysines were 
substituted by alanine, or 2. five lysines were present and one was replaced by alanine) 
within the channel of FhuA Δ1-159 and identified position 556 as a key position to sterically 
control compound fluxes. Furthermore, molecular dynamic simulations confirmed position 
556 as the least fluctuating among the six investigated lysines. Based on these studies, 
position 556 was selected for coupling of the metal complex. Coupling of the metal complex 
to the amino acid side chain should occur via the –OH group of a single serine, or the –SH 
group of a cysteine. Two variants FhuA Δ1-159_S556 and FhuA Δ1-159_C556 were generated 
by a) replacement of all 37 existing serines by asparagines and introducing a single serine at 
position 556 and by b) introducing a single cysteine at the respective position. A synthetic 
gene was ordered for FhuA Δ1-159_S556. FhuA Δ1-159_C556 was generated by site directed 
mutagenesis using FhuA Δ1-159 as template. For establishment of the proof of concept it 
was decided to concentrate on the –SH coupling. Due to steric hindrance of the metal 
catalyst to position 556 and analytical challenges, FhuA Δ1-159_C556 was optimized by 
developing a further variant: FhuA Δ1-159_C556_tev (for further details see A.2.5.).  
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Expression of all variants started from freshly transformed E. coli omp8 cells, culturing them 
12-16 h in a preculture (100 mL Erlenmeyer flask, 20 mL media) and transferring them for 
expression to a 1L Erlenmeyer flask (250 mL media). Different media were tested to reach 
highest protein expression. FhuA Δ1-159_C556_tev required extensive expression 
optimization in terms of temperature, starting OD of the mainculture and time of induction. 
Optimization additionally included starting the expression from glycerol stocks and 
maintaining the cells in a continuous culture. Expression of FhuA wildtype, FhuA 
Δ1-159_C556 and FhuA Δ1-159_C556_tev was additionally performed in one-day 
fermentation with a working volume of 10 L.  
Extraction was initially performed by the method developed by Nallani et al. [39]. Some 
optimizations concerning centrifugation speed and buffer composition were done (protocols 
see section 11.2., protocols). Strong impurities in extracted FhuA Δ1-159_S556 fractions 
were the motivation for the development of a chloroform/methanol extraction step with 
subsequent trifluoro-ethanol/chloroform extraction. To further increase the protein 
extraction yield, extraction of FhuA Δ1-159_C556, was pursued by using the green solvents 
2-MeTHF and CPME [76]. In parallel, A. Whiton solubilized the protein with different 
concentration of the detergents fos-choline-12 (Fc-12), n-dodecyl-β-D-maltoside (DDM) or 
n-decyl-β-D-maltoside (DM) [93]. However, the current methods yield less than 1 mM 
protein per liter. To detect the coupling between the maleimide linker and the protein by 
e.g. NMR, at least 1 mM protein (or better 1 M per liter) is required [94]. Meantime, besides 
challenges to reach higher protein yields, steric hindrance of the metal catalyst to position 
556 led to the development of an optimized FhuA variant (FhuA Δ1-159_C556_tev). In 
cooperation with M. Arlt (Institute of Biotechnology, RWTH Aachen University), a crude 
extraction method, based on membrane disruption with n-hexane/ethanol and solubilization 
of the protein in sodium dodecyl sulfate (SDS), followed by unfolding with urea and refolding 
by PE-PEG, was developed. This method presented the desired amounts of 
FhuA Δ1-159_C556_tev. Further concentration experiments for extracted FhuA 
Δ1-159_C556_tev were performed to compare the following different methods: aquacide, 
vacuum evaporator, lyophilizer, vacuum desiccators and centrifugal filter units. 
Chapter A focused on the engineering, expression, purification as well as concentration of 
the aforementioned FhuA variants.  
 
2. Protein engineering (including MD simulations) 
Table 1 shows the bacterial strains used for engineering and expression of the FhuA variants. 
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Strain Genotype Source 
E. coli DH5α 
F−Ф80dlacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1 
hsdR17 (rK
−, mK+) phoA supE44 
λ- thi-1 gyrA96 relA1 
Invitrogen, Karlsruhe, Germany 
E. coli BE BL21 (DE3) omp8 
F- hsdSB (rB
- mB
-) gal ompT dcm 
(DE3) ΔlamB ompF::Tn5 ΔompA 
ΔompC 
Received as a gift from R. 
Koebnik [95] 
Table 1: Bacterial strains used for genetic engineering (E. coli DH5α) and expression (E. coli BE BL21 
(DE3)  omp8) of FhuA variants. 
 
2.1. P1 (FhuA wildtype) 
fhuA was originally provided on the pHK763 vector by Prof. V. Braun [92] and cloned into the 
standard isopropyl-β-D-thiogalactopyranoside (IPTG)  inducible  expression  system pPR-IBA1  
(IBA  GmbH,  Göttingen,  Germany), using an EcoRI restriction site at the 5’-end and an XhoI 
restriction site at the 3’-end [38]. The wildtype and all deletion variants (apart from 
FhuA Δ1-159_C556_tev) contain a his6-tag (PD-H6-DLA) after amino acid-position P405 [32]. 
 
2.2. P2 (FhuA Δ1-159) 
FhuA Δ1-159 originated from the FhuA wildtype (pPR-IBA1 vector, restriction sites EcoRI and 
XhoI). Using PCR, Nallani et al. [38] deleted the first 159 amino acids, forming the cork 
domain and turned the FhuA protein into a passive diffusion channel [96]. Based on 
PDB-entry 1BY3, the deletion variant Δ1-160 was renamed to Δ1-159 starting from 2011.  
 
2.3. P3 (FhuA Δ1-159_S556) 
FhuA Δ1-159_S556 derived from FhuA Δ1-159. The position named “556” was introduced 
using PDB-entry 1BY3, deleting the first 159 amino acids forming the cork domain, counting 
the ensuing proline (position 160 in PDB 1BY3) even if it is absent in the mutated sequence. 
Subsequent amino acids were counted in a regular way, including the his6-tag with its 
adjacent five amino acids.  
The sequence of FhuA Δ1-159 contains 37 serines. In order to have only one single serine at 
position “556”, all serines were removed and exchanged by asparagines. The existing glycine 
at position “556” was replaced by serine. A synthetic gene, delivered in a pMK-RQ vector 
with kanamycin resistance, was ordered from GENEART [Quality Assurance Documentation: 
0942428] (GENEART, Regensburg, Germany) (Figure 7).  
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fhuA Δ1-159_S556-pPR-IBA1 
section 11.2., protocols) into
pPR-IBA1 showed colonies. Several colonies were selected to verify presence of the gene 
using a “restriction check” with 
 
Figure 9: Polyacrylamid gel electrophoresis
ligated to pPR-IBA1 (2816 bp),
Germany), 1 = ligated vector sample 1, 2 = ligated vector sample 2. 
 
8: Vector map pPR-IBA1. 
 Compound 
6 µL fhuA Δ1-159_S556 
2 µL pPR-IBA1 
µL (5 U) T4 ligase (EL0011) 
1 µL A. dest 
1 µL 10x T4 ligase buffer (B69) 
FhuA Δ1-159_S556 with pPR-IBA1.
(with its respective controls) was transformed (protocol see 
 E. coli DH5α. Only plates with FhuA Δ1-159_S556
EcoRI and NcoI (Figure 9). 
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 ligated to 
 as FhuA) 
-Rot, 
4 EXPERIMENTAL CHAPTER A: Engineering, expression, extraction, purification 
26 
 
 
The plasmid was sequenced for fhuA Δ1-159_S556 (MWG Eurofins, Ebersberg, Germany). 
Glycerol stocks (25 %) of the variant are stored at -80 °C.  
 
2.4. P4 (FhuA Δ1-159_C556) 
FhuA Δ1-159_C556 derived from FhuA Δ1-159 [36] using QuikChange site directed 
mutagenesis, restriction sites EcoRI and XhoI, as well as the pPR-IBA1 expression 
system [97]. Oligo nucleotide primers 5`-GTA TAA TCT CAC TTG CAC CAA CAA CCT GAT-3` 
(forward) and 5`-ATC AGG TTG TTG GTG CAA GTG ACA TTA TAC-3` (reverse) were used to 
introduce the cysteine at position 556. 1st and 2nd PCR as well as DpnI digestion were 
performed according to Table 4 (p.26-27).  
 
Amount Compound 
1 µL (13 ng) 
Template (FhuA Δ1-159-
pPR-IBA1) 
7.5 µL Primer fwd or rev 
0.5 µL (200 µM) dNTP-Mix 
2.5 µL Pfu-polymerase-buffer 
0.25 µL (1 U) Pfu-polymerase 
25 µL A. dest 
 
Degree in °C Time in sec 
98 30 
98 10 
55 30 
72 120 
 
Both samples were mixed and split to 2x 25 µL. 
 
Degree in °C Time in sec 
98 30 
98 10 
55 30 
72 120 
 
Template DNA was digested with FastDigest DpnI from Fermentas (St. Leon-Roth, Germany). 
 
 
3x 
16x 
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Amount Compound 
5 µL 30 
2 µL 10 
1 µL DpnI (FD1703) 
12 µL A. dest 
Table 4: Protocol for 1st and 2nd PCR for generation of FhuA Δ1-159_C556 (from FhuA Δ1-159) and 
DpnI digestion. 
 
Subsequently, PCR Clean-Up (QIAquick PCR Purification Kit, QIAGEN, Hilden, Germany) and 
transformation (see section 11.2., protocols) were performed.   
The plasmid was sequenced for fhuA Δ1-159_C556 (MWG Eurofins, Ebersberg, Germany). 
Glycerol stocks (25 %) of the variant are stored at -80 °C.  
 
2.5. P5 (FhuA Δ1-159_C556_tev) 
Establishment of cysteine-titration and MALDI analysis with FhuA Δ1-159_C556 did not 
confirm the expected results: cysteine-titration should show a fluorescence decrease upon 
coupling of Bodipy FL L-cystine (Invitrogen) or ThioGlo 1 (Merck) to position C556 of the 
protein. Since no decrease could be detected, possible steric hindrance between E512 and 
N559 (Figure 10) should be removed. In terms of MALDI, no mass spectra was obtained by 
digestion of FhuA Δ1-159_C556 with trypsin, AspN or GluC. Within this context it was 
obvious that there was need to engineer a new FhuA variant. Molecular Dynamics (MD) 
computer simulations were selected to see the physical movements of atoms and molecules 
and select convenient amino acids to tackle the aforementioned problems around the 
labeling site. Simulations were performed in cooperation with Dr. M. Bocola (Institute of 
Biotechnology, RWTH Aachen University). The new generated variant was named 
FhuA Δ1-159_C556_tev.  
 
 
 
 
 
 
 
Figure 10: MD simulations of FhuA Δ1-159_C556 show interactions of E512***N559, shielding C556, 
the catchy position. 
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Salt bridge substitution (FoldX plugin for YASARA) 
The algorithm FoldX estimates the interaction contributing to protein stability. In this study, 
a force field energy calculation of amino acids E512 and N559 was applied in which the two 
investigated amino acids were substituted by all other 19 amino acids (Table 5).  
 
According to Table 5, the best 
substitution for E512 is 
phenylalanine. For position N559, 
phenylalanine is also proposed but 
position 559 is very close to 556 
and therefore a phenylalanine at 
this position will most probably 
shield C556 and the catalyst 
cannot bind. The same might be 
true due for tyrosine. Leucine 
cannot be used due to 
interactions with leucine at 
position 560. The next alternative 
is methionine or valine which can 
be chosen for substitution. In this 
case it was decided to mutate 
N559V.   
 
 
 
 
 
Tobacco etch virus (TEV) cleavage site incorporation 
Since protein digestion with trypsin, AspN and GluC was not successful, a TEV-cleavage site 
should be introduced for C556 labeling detection. Addition of one TEV-cleavage site (e.g. 
insertion in the external loop above the C556) leads to protein parts of around 20 and 
40 kDa. MALDI analysis of a hydrophobic protein of that size, which additionally is covered 
by detergents, will be difficult. Therefore it was decided to use two restriction sites in the 
extracellular loops 7 and 8 (in the following referred as loop A and B). Internal restriction 
 
Position 
E512 
Stabilization 
energy 
(kcal/mol) 
 
Position 
N559 
Stabilization 
energy 
(kcal/mol) 
PHE -0.17 
 
PHE -1.78 
ILE -0.17 
 
LEU -1.74 
LYS -0.1 
 
TYR -1.57 
MET -0.09 
 
MET -1.42 
ASN -0.06 
 
VAL -1.40 
ARG -0.03 
 
LYS -1.24 
GLU -0.01 
 
ILE -1.22 
TYR 0 
 
TRP -0.96 
ASP 0.06 
 
ARG -0.87 
HIS 0.12 
 
ALA -0.76 
CYS 0.15 
 
CYS -0.59 
THR 0.19 
 
GLN -0.49 
VAL 0.21 
 
GLU -0.48 
SER 0.25 
 
HIS -0.39 
LEU 0.25 
 
SER -0.13 
ALA 0.34 
 
ASN 0 
GLY 0.53 
 
GLY 0.05 
GLN 0.54 
 
THR 0.29 
TRP 0.74 
 
ASP 0.51 
PRO 2.07 
 
PRO 4.93 
 
Table 5: Energetic analysis of FhuA Δ1-159_C556 (position 
E512 and N559) by FoldX. 
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sites were neglected because it is known that the lower part of FhuA is covered with 
detergent and this might lead to difficulties for the TEV-protease, to cut this part. In terms of 
TEV-cleavage site incorporation in the external loops (Figure 11), two alternatives were 
analyzed: TEV-recognition site ENLYFQG could be either extended to the loop forming amino 
acids (VGKD_ENLYFQG_GNIF, ADPE_ENLYFQG_GSFF), or it could be inserted 
(VGK_ENLYFQG_NIF, ADP_ENLYFQG_FF), while some of the amino acids in the loop are 
deleted. To decide which incorporation is best, the energy of the restriction sites as well as 
the surface accessibility was calculated with YASARA (Table 6). 
 
Figure 11: Extracellular loops A and B of FhuA Δ1-159_C556_tev were chosen for incorporation of the 
TEV-recognition site. This figure shows the addition of the TEV-recognition sides (structural model of 
amino acids) using extension (VGKD_ENLYFQG_GNIF, ADPE_ENLYFQG_GSFF). 
 
Energy of restriction sites 
 
Accessible surface area 
 
Loop A Loop B 
  
Loop A Loop B 
Extension -975 -1100 
 
Extension 1075 914 
Insertion -1042 -1043 
 
Insertion 986 1036 
Table 6: Energy and surface accessibility of external loop A and B for extension 
(VGKD_ENLYFQG_GNIF, ADPE_ENLYFQG_GSFF) and insertion of TEV-cleavage sites 
VGK_ENLYFQG_NIF, ADP_ENLYFQG_FF). 
 
The energy of the restriction site by extension is preferred by loop B, while insertion is 
advantageous for loop A. Accessibility of surface area of loop A favours extension. For loop B 
it is vice versa. Due to controvert results, it was decided to extend the restriction site to the 
B 
A 
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loops because if difficulties in protein expression 
removed by PCR and inserted at another position.  
The synthetic gene for the new variant
Germany [Quality Assurance Documentation: 11AAPJKP])
metallozymes, exhibits the following differences
amino acid exchanges (E512F, N559V)
(loop A, loop B), removal of the
acids). The gene was delivered in a pMK
Figure 12: Vector map 
 
Multiplication and isolation of the plasmids was done as 
(section A.2.3.). Restriction of the insert and the pPR
for 2 hours at 37 °C. After restriction, PCR 
Hilden, Germany) was performed. 
 
Amount
1 µ
1 µ
Total volume: 50 
Table 7: Restriction protocol for 
Inserts were separated from the vector using p
(0.8 % agarose, TAE (0.04 M Tris
occur, the cleavage site can easily be 
 
 FhuA Δ1-159_C556_tev (GENEART, Regensburg, 
, being applicable as a scaffold for 
 compared to FhuA Δ1
, two TEV-restriction site incorporation via extension
 his6-tag including its adjacent amino acids
-RQ vector with kanamycin resistance (
FhuA Δ1-159_C556_tev_pMK-RQ. 
described for 
-IBA1 vector (Table 
clean-up (QIAquick PCR Purification Kit, QIAGEN, 
 
 Compound 
2 µg Plasmid DNA 
L (20 U) EcoRI (R0101) 
L (20 U) XhoI (R0146) 
x µL A. dest 
5 µL 10x NEBuffer (B0101S) 
µL. Enzymes were distributed 
from NEB (NEB, Ipswich, MA, USA). 
FhuA Δ1-159_C556_tev_pmk-RQ and 
 
reparative DNA
-Acetate, 1 mM EDTA), gel red (1.6 µL for 
 
30 
 
-159_C556: two 
 
 (in total 11 amino 
Figure 12).  
 
FhuA Δ1-159_S556 
7) was carried out 
pPR-IBA1. 
-gelelectrophoresis 
50 mL agarose-gel, 
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Biotium, Hayward, CA, USA), 40 minutes, 100
extraction from agarose gel, Macherey Nagel, Düren, Germany). 
pPR-IBA1 were ligated (15 °C, ON
Amount
2.5 µ
2.5 µ
1 
Table 8: Ligation protocol 
 
After plasmid transformation 
a “restriction check” with EcoRI
 
Figure 13: PAGE of FhuA Δ1-159_C556_tev 
(2816 bp), restriction check. M = mark
vector sample 1, 2 = ligated vector sample 2, 3 = pPR
 
The plasmid was sequenced for 
Germany). It was found out that the TEV
VGK_ENLYFQG_DGNIF, ADPEG_ENLYFQG_
-80 °C.  
 
3. Expression, Extraction and Purification
In the following section, expression, extraction and purification steps 
described. For some variants the same protocol was used. If this is the case, more details on 
the method are given when the method is mentioned the first time. S
preparation is common for all variants, it is listed in the subsequent paragraph.
 
 
 V), followed by DNA extraction (protocol: DNA 
fhuA Δ1-
, Table 8) using T4 ligase (Roche, Penzberg, Germany).  
 Compound 
L (20 ng/L) fhuA Δ1-159_C556_tev 
L (40 ng/L) pPR-IBA1 
µL (1 U) T4 ligase (10481220001) 
1 µL 10x T4 ligase buffer (B69) 
FhuA Δ1-159_C556_tev with pPR-IBA1.
(section 11.2., protocols), vector-insert ligation was verified by 
 and XhoI (Figure 13). 
 
 (1818 bp) (abbreviated as FhuA) 
er (SM031, Fermentas, St. Leon-Roth, Germany), 1
-IBA1 vector. 
FhuA Δ1-159_C556_tev (MWG Eurofins, Ebersberg, 
-recognition site was accidently incorporated at 
SFF. Glycerol stocks (25 %) of the variant are stored at 
 
for each variant are 
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159_C556_tev and 
 
 
ligated to pPR-IBA1 
 = ligated 
ince SDS-sample 
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Details for SDS-sample preparation 
For SDS-analysis during expression, cells were centrifuged (10 min, 10000 rpm, 4 °C, 
Eppendorf 5415 D, Hamburg, Germany). The supernatant was discarded while the pellet was 
resuspended in 40 µL of lysis buffer (1 % SDS, 20 mM Tris-HCl, 0.2 M 
ethylenediaminetetraacetic acid (EDTA), pH 8). Samples were briefly sonicated, mixed with 
10 µL 4x loading dye (Tris-HCl, 200 mM (pH 6.8), 40 % glycerol, 8 % SDS, 400 mM 
dithiotreitol, 0.4 % bromphenol blue, up to 15 mL MilliQ) and cooked for 5 min at 95 °C. A 
10 % acrylamide gel (resolving  gel: 7.15 mL MilliQ, 3.75 mL 40 % acryl amide, 3.80 mL 1.5 M 
Tris (pH 8.8), 0.15 mL 10 % SDS, 0.15 mL ammonium persulfate (APS), 0.006 mL 
tetramethylethylendiamine (TEMED)  – stacking gel: 2.225 mL MilliQ, 0.375 mL 40 % acryl 
amide, 0.380 mL 1 M Tris (pH 6.8), 0.03 mL 10 % SDS, 0.03 mL APS, 0.004 mL TEMED) was 
prepared and proteins were separated (buffer: 25 mM Tris, 250 mM Glycine (pH 8.3), 0.1 % 
SDS – Biorad Mini-PROTEAN  system  (Hercules,  California,  USA), 18 mA (per gel) , 400 V, 
50 W, 70 min).  
Markers for SDS-analysis were purchased from Thermo Scientific (St. Leon-Rot, Germany, 
(a) SM0431, unstained protein molecular weight marker (14.4-116.0 kDa), (b) SM0671, 
PageRuler prestained protein ladder (10-170 kDa)).  
 
3.1. P1 (FhuA wildtype) 
A detailed expression and extraction protocol of FhuA wildtype can be found in section 11.2., 
protocols (Expression of FhuA and variants, Extraction of FhuA and variants), a summary of 
the method is listed below. 
Plasmids were transformed (see section 11.2., protocols) into E. coli omp8 cells. After over 
night incubation, a single clone was transferred to 20 mL LBA for preculture cultivation. 
12-14 hours later, a mainculture (OD600 0.1) was inoculated. IPTG (1 mM) was added to the 
cells when OD600 reached 0.7-0.8. After 5-6 hours, cells did not longer divide and were 
harvested while expression was checked on an SDS-acrylamide gel. The pellet can was stored 
at -20 °C. Homogenizer and French Press (EmulsiFlex-C3, Avestin Europe GmbH, Mannheim, 
Germany) were used to break the cell walls whereas three alternating incubation-
centrifugation steps solubilized the protein. Finally, the solubilized protein (77 kDa) was 
retained in the supernatant containing 3 vol% octyl-polyoxyethylene (oPOE), while large 
amounts remain in the pellet fraction (Figure 14). The extraction described is specified 
therein as “standard extraction” (in opposition to “organic solvent” extraction procedures 
which will be described later on).  
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Figure 14: SDS-gel of FhuA wildtype 
and non-solubilized protein remaining in the pellet
 
Protein concentrations were determined with 
(Thermo Scientific, St. Leon-Roth, Germany), yielding 
quality of the extraction. The concentration is equal to 6.8 mg protein extracted 
liter culture broth. Protein puritie
(IMAGE-J analysis, Version 1.42)
For large-scale protein production, the Biostat ED fermenter 
Germany), with a working volume of 10 L
cells were transformed according to the 
preculture optical density is between
filled with 20 mL LBA. Each flask was
(12-14 hours, 250 rpm, 37 °C), 
OD600 0.1 (TY-media, fermentation settings: 150 rpm, 37 °C, six
with air). Sterile (0.2 µm filter) antifoam (pluriol, 0.5 mL) and ampicillin (0.1 mg/ mL) were 
added with a syringe. Fermenter settings O
the “MFCS/shell” software.  
 
(77 kDa) (abbreviated as FhuA) extracted with 3 
 (P). M = marker SM0431 Fermentas.
the bicinchoninic acid
around 0.5 mg/mL
s, determined with Image Processing and Analysis in Java 
, were around 70 %.  
(Sartorius, Göttingen, 
 was used (Figure 15). To start the fermentation, 
protocol (section 11.2., protocols)
 2-2.5, therefore 40 x 100 mL Erlenmeyer
 inoculated with a single clone. Aft
x mL cell culture were transferred into the fermenter, 
-flate disc
2, pH, rpm and temperature were recorded 
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vol% oPOE (S) 
 
-assay (BCA-assay) 
 depending on the 
from one 
. From experience, 
 flasks were 
er incubation 
to reach 
-turbine, sparged 
with 
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Figure 15: 10 L Biostat
 
Samples for SDS analysis and monitoring of cell growth were taken every 1
Induction (1 mM IPTG) took 
sampling, cells expressed the protein 
after IPTG-addition, an OD600 
the stationary-phase, for that reason they were harvested 
5810 D, Hamburg, Germany). 
Pellets obtained by fermentation were extracted according to the standard extraction 
protocol (see section 11.2, protocols, Extraction protocol for
impurities were removed by gel
München, Germany). 3 mL Dextran Blue (2000 kDa) was used as a standard (
Dextran Blue was dissolved in 3 mL (1 mM KP
solution were added to the column. 0.5 mL fractions were collected, the protein appeared in 
fraction 3-10, while fraction Nr. 
IMAGE-J). The purification step
All fractions Nr. 3 were merged and 1 
precipitate. The sample was further used for stability studies in tetrahydrofuran (THF), 
ethanol (EtOH) and chloroform/methanol (C/M) 
 
3.2. P2 (FhuA Δ1-159) 
Apart from FhuA wildtype, all variants are lacking the cork domain
conditions were optimized with FhuA Δ1
 
 ED fermenter (right side) with control unit (left side)
place after 2.25 hours, cells reaching OD600
(proven by SDS-analysis, data not shown) 
3.4 was reached. OD-monitoring showed that the cells entered 
(20 min, 3220 g, 4
 
 FhuA and variants
-filtration (12 cm column, Sephadex G25-fine, GE
i, 1 mM EDTA, pH 8)) before 3
3 was the most purified one (around 80 %
 was repeated seven times with 3 mL of the original sample. 
vol% oPOE was added since the protein seemed to 
[46].  
. Therefore
-159. The general procedure 
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. 
-1.5 hours. 
 1.0. At the next 
and 3.0 hours 
 °C, Eppendorf 
). Protein 
 Healthcare, 
a small spatula 
 mL FhuA protein 
, determined with 
, expression 
was based on the 
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protocol “Expression of FhuA and variants” (section 11.2., protocols), while different 
expression media were tested: minimal medium M9 and rich media SOC, SOB (with and 
without glucose), TY as well as TY505 (Figure 16). All media were supplemented with 
ampicillin (100 µg/mL).  
 
Figure 16: Optical density over time of FhuA Δ1-159, growing in M9, TY, TY505, SOC, SOB 
(+/- glucose). Cells were induced with IPTG (0.1 M) after 150 min.  
 
Except cells growing in M9-medium, they were harvested after 465 min with OD600 2-3.5. For 
the expression check on SDS-page, 1 mL bacterial culture was centrifuged and prepared for 
SDS-gel analysis. All cultures expressed the desired protein (Figure 17), while according to 
IMAGE-J analysis, highest protein expression level (35 % of total expressed proteins) were 
found in TY-media. Besides FhuA Δ1-159 expressed in M9-media, expression in SOC, SOB 
(with and without glucose) and TY505, yielded between 24-28 % (of the total expressed 
proteins). Extraction (0.3-0.5 mg/mL) of TY-media expressed FhuA Δ1-159 was done with the 
standard protocol (section 11.2. protocols, Extraction protocol for FhuA and variants) using 
3 vol% oPOE as detergent (Figure 18). Purity, analyzed by IMAGE-J was around 75 %. A 
protein concentration of 0.3-0.5 mg/mL is equal to 4-6.8 mg protein extracted from one liter 
culture broth. 
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Figure 17: SDS-page of FhuA Δ1
(M9, TY, TY505, SOC, SOB (without
analysis before induction (BI), 90 min after induction (AI
that multiple gels were merged, 
 
Figure 18: SDS-page of FhuA Δ1
and protein remaining in the pellet (P). M = marker, SM0431 Fermentas. 
made of three different gel figures)
 
Besides successful fermentat
settings as described for FhuA (see A.3.1.), the modified s
0.5 vol% DDM as the second step, rather than 3 
extraction (Figure 19). The protocol was originally developed for FhuA Δ1
A.3.4.), ensuing good results.  
-159 (63.0 kDa) (abbreviated as FhuA) expressed in different me
 glucose). 1 mL cell culture was centrifuged and used for SDS
90) and 315 min after induction (AI
while each single gel exposed a marker (M, SM0431 Fermentas).
 
-159 (63.0 kDa) (abbreviated as FhuA) extracted in 3 
(Note that the figure was 
.   
ion of FhuA Δ1-159 (10 L Biostat ED fermenter) with the 
tandard extraction, based on 
vol% oPOE, did not result in proper protein 
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dia 
-
315). Note 
 
vol% oPOE (S) 
-159_C556 (see 
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Figure 19: SDS-page of FhuA Δ1
standard protocol. 0.1 vol% oPOE were used in the first and 0.5
M = marker, SM0671 Fermentas.
 
3.3. P3 (FhuA Δ1-159_S556) 
Expression and extraction of FhuA Δ1
used for expression and extraction of FhuA
section 11.2., protocols (Expression of FhuA and variants
variants).  
The standard extraction procedure did not 
et al. [98], a chloroform/methanol 
trifluoroethanol/chloroform (TFE/C) 
protocols, FhuA Δ1-159_S556 isolation with TFE
trifluoroethanol are traditionally used to solubilize peptides for NMR studies. The separation 
by trifluoroethanol/chloroform 
proteins [98].  
FhuA Δ1-159_S556 extracted with the 
around 0.3 mg/mL protein (equal to 1.5 mg protein extracted from one liter culture broth) 
and a purity of around 80 % (IMAGE
Figure 20: SDS-gel of FhuA Δ1
standard protocol using 3 vol%
M = marker, SM0431 Fermentas.
 
-159 (63.0 kDa) (abbreviated as FhuA) extracted according to the 
 vol% DDM in the second step (S). 
 
-159_S556 were performed according to the protocols 
 and FhuA Δ1-159. Protocols are given in 
 and Extraction 
yield the expected results. Inspired by Deshusses 
(C/M) extraction step (3:1) with subsequent 
extraction, was performed (protocol see 
-chloroform). High concentratio
is known to extract a number of integral membrane 
TFE/C organic solvent procedure (
-J analysis).  
 
-159_S556 (64.0 kDa) (abbreviated as FhuA) 
 oPOE and subsequent trifluoroethanol/chloroform extraction
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of FhuA and 
section 11.2., 
ns of 
Figure 20) yielded 
extracted with the 
 (S). 
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3.4. P4 (FhuA Δ1-159_C556) 
FhuA Δ1-159_C556 was expressed 
extraction protocol, as described for th
Extraction of FhuA and variants)
Figure 21: SDS-gel of FhuA Δ1-
culture was centrifuged and used for SDS
IPTG. The different numbers represent expression 
six cultures expressed the protein. 
 
Figure 22: SDS-gel of FhuA Δ1
standard expression protocol using 3 
after 2nd/3rd centrifugation, S1-S3 = supernatant after 1
 
Protein concentrations were determined with 
Roth, Germany), yielding around 
The concentration is equal to 4
To improve protein purity, after the standard extraction with 3
protein extraction with organic solvents was performed. Organic solvent
chloroform is mainly, but not exclusively,
proteins [98, 99]. In this study
an alternative protocol based on green 
(Figure 21) and extracted (Figure 22) 
e other variants (see section 11.2., protocols, 
.  
159_C556 (63.1 kDa) (abbreviated as FhuA) expression. 
-analysis before induction (BI) and after induction (AI) with 
using different clones. Note that only five out of 
M = marker, SM0431 Fermentas. 
 
-159_C556 (63.1 kDa) (abbreviated as FhuA) 
vol% oPOE (S3). M = marker, SM0431 Fermentas, P2/P3 = pellet 
st/2nd/3rd centrifugation.  
the BCA-assay (Thermo Scientific, St. Leon
0.3-0.6 mg/mL while purity was 65 % 
-8 mg protein extracted from one liter culture broth. 
 vol% oPOE, an additional 
 extraction 
 known from chloroplast membrane 
, extraction with chloroform was investigated
organic solvents 2-MeTHF and CPME
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with the standard 
 
1 mL cell 
extracted with the 
-
(IMAGE-J analysis). 
 
based on 
 in comparison to 
. The idea was to 
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use the solvent for solubilizing membrane components while hydrophobic proteins 
aggregate. As known from inclusion body expression, FhuA-aggregates can easily be 
solubilized in urea and refolded by dialysis in presence of PE-PEG [43]. As organic solvents 
CM, 2-MeTHF and CPME were applied in different concentrations: CM/water mixtures were 
analyzed: 1:1:4, 2:1:3 and 3:1:4. Water/2-MeTHF and water/CPME were analyzed 1:1 and 
1:2. The organic solvent extraction protocol is given in section 11.2., protocols (FhuA 
isolation with 2-MeTHF or CPME). Structural integrity and functionality of FhuA Δ1-159_C556 
was confirmed by CD-measurements and 3,3`,5,5`-tetramethylbenzidine (TMB) conversion 
via Horse Radish Peroxidase (HRP) (see section 11.2., protocols, Liposome preparation (1.4), 
Liposome purification (2.4), Extrusion of liposomes (3.4), HRP-TMB assay (4.4)). The 
developed extraction procedure and the structural analysis of FhuA Δ1-159_C556 were 
submitted to the Journal Chromatography B [76].   
SDS-analysis and the BCA-assay showed highest amounts of FhuA protein in STD > 
1:2 CPME > 1:1 2-MeTHF extraction. Calculating the amount of extracted protein obtained 
from one liter culture broth, highest protein amounts are obtained using the extraction 
based on 1:2 CPME > 1:1 2-MeTHF > STD. Best purities, 95 % and 80 %, were obtained by 
means of 1:1 2-MeTHF and 1:2 CPME (Figure 23).  
 
Figure 23: SDS-gel of FhuA Δ1-159_C556 (63.1 kDa) (abbreviated as FhuA Δ1-159_C) extracted with 
only the standard expression protocol using 3 vol% oPOE or additionally with different concentration 
of 2-MeTHF, C/M or CPME. Protein concentrations determined with the BCA-assay and obtained in 
extraction of one liter culture broth, are given below. The figure was taken from Tenne et al. [46] 
with slight modifications.  
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In parallel to the green solvent extraction protocol, 
extracted protein were made 
detergents included Fc-12, DM and DDM (A
performed according to the standard extraction protocol (
protocol for FhuA and variants)
amount of DM, DDM or Fc-12 for the second step (
(around 0.6 mg/mL) with FhuA purity of 65
0.5 vol% (w/v) DDM. The concentration is equal to 8.5 mg protein extracted from one liter 
culture broth. Fc-12 showed strong impurities of other proteins. 
Figure 24: SDS-gel of FhuA Δ1-159_C556 (63.1 kDa) extracted with the modified standard expres
protocol using 0.1 vol% oPOE in the first and 3 
DDM/ Fc-12 (v/v) as the second step. The figure was taken from 
 
For large-scale protein production, the Biostat ED fermenter, 
was used. Preculture preparation, fermentation settings and fermentation were done as 
described for FhuA wildtype (see A.3.1.)
A sample (1.6 x 108 cells) for monitoring of cell growth 
26) was taken every 60-90 min
reaching OD600 0.7.  
improvements concerning the amount of
by applying other detergents than oPOE
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Figure 25: Optical density over time for FhuA Δ1
 
Figure 26: SDS-gel of FhuA Δ1
expressed the protein after induction with IPTG. 
centrifuged BI (before induction
point in minutes. M = marker, SM0431 Fermentas.
 
3.5. P5 (FhuA Δ1-159_C556_tev)
Expression (Figure 27) of FhuA Δ1
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continuous culture or glycerol stock 
FhuA Δ1-159_C556_tev).  
 
Figure 27: SDS-gel of FhuA Δ1-159_C556_tev (63.5 kDa)
clone 1, 6 and 7 did not express FhuA while
numbers, M = marker, SM0431 Fermentas.
 
To pursue the question if the c
the plasmid, plasmid isolation was performed 
Hilden, Germany), followed by a 
for restriction protocol see Table 
identified by PAGE. The bands represent 
Furthermore, the isolated plasmids were sent for sequencing. No mutation was found. 
Cells expressing FhuA Δ1-159_C556_tev were 
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extraction protocol) were utilized for the organic solvent extraction ba
1:1 water/2-MeTHF or 1:2 water/CPME (
2-MeTHF or CPME). CPME extraction displayed extracted protein but strong impurities while 
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 clone 7 expresses a different protein. 
 
lones not expressing the protein (Nr. 1 and 6, 
(QIAGEN® Plasmid Purification Kit, QIAGEN,
restriction check with EcoRI restriction and 
7). Two bands with a size of 1704 bp and 2816 bp were 
FhuA Δ1-169_C556_tev
extracted according to the standard protocol 
using 
 (Figure 28).  oPOE did not result in protein extraction, 
using 0.1 vol% oPOE in a first step an
HEOS) (v/v) in a second step, were 
 while small amounts of 
vol%
section 11.2., protocols, FhuA iso
. Due to low resolution of the 
SDS-analysis of the samples extracted with DM, 
Figure 28). 
 
42 
 
 (Expression of 
 
. Note that 
 1-7 = clone 
Figure 27) lost 
 
XhoI (amounts 
 and pPR-IBA1.  
 
0.1 vol% oPOE in a 
d 0.5 % DM, 
 oPOE (standard 
sed on 
lation with 
4 EXPERIMENTAL CHAPTER A: Engineering, expression, extraction, purification
Figure 28: SDS-gel of FhuA Δ1-159_C556
standard extraction using 0.1% 
HEOS (v/v) as a second step. Additionally, oPOE
organic solvent extraction using 1:1 
Fermentas. 
 
Phosphate and phenylmethanesulfonyl
removed due to incompatibilities 
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membrane [100]. The aggregated protein was unfolded in SDS and refolded 
dialysis with PE-PEG (section 11
FhuA_tev solubilization with SDS and refolding by dialysis
refolded protein sample represents
Protein concentration determined with 
a protein amount of 800 mg per liter extracted culture broth. 
Figure 29: SDS-gel of FhuA Δ1-159_C556_tev (63.5 kDa) 
standard extraction using 0.1 vol%
was subsequently treated with n
The gel was intentionally overloaded (
Fermentas. 
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The idea to directly treat the expression pellet of FhuA Δ1-159_C556_tev with the above 
mentioned organic solvent method and therefore to shorten the extraction time and costs 
for the detergent oPOE, malfunctioned. According to SDS-analysis, the sample exhibited 
strong impurities and furthermore the sample was less stable upon storage. It was 
concluded that oPOE extraction is necessary to solubilize unpreferred proteins and since the 
solution is yellowish, also lipids.  
 
FhuA Δ1-159_C556_tev, the final variant for the application as metallozyme was used to 
study six different concentration methods: aquacide, vacuum evaporator, lyophilizer, 
vacuum desiccator and Vivaspin 15 centrifugal concentrator. The starting volume was 4 mL 
with a concentration of 0.9 mg/mL FhuA Δ1-159_C556_tev (buffer: 0.125 mM PE-PEG, 
1 mM EDTA, pH 7.5). Further information on each method are listed below. 
a) Aquacide: sample was transferred into a dialysis membrane (MWCO 12-14 kDa, 
Spectral/POR, Spectrum Laboratories, California, US) and covered with a layer of 
aquacide (circa 3 mm). Gentle shaking at room temperature until the desired amount 
of solvent was absorbed by the powder. The dialysis membrane was opened and the 
remaining solution was taken out.  
b) Vacuum evaporator: the protein sample was transferred into a 50 mL round bottom 
flask and connected with the vacuum evaporator (VWR, Darmstadt, Germany), 
settings: 100 rpm, RT, 35 mbar.  
c) Lyophilizer: the protein sample was frozen at -80 °C for 90 min and transferred to the 
lyophilizer (Alpha 1-2 CD plus, Martin Christ Gefriertrocknungsanlagen GmbH, 
Osterode am Harz, Germany).  
d) Vacuum desiccator: the space below the platform was filled with silica gel beads, the 
sample was put into the vacuum desiccator, the lid was closed and vacuum was 
drawn.  
e) Vivaspin 15: the column (MWCO 10 kDa, Sartorius Stedim Biotech GmbH, Göttingen, 
Germany) was washed (0.125 mM PE-PEG, 1mM EDTA, pH 7.5) for 20 min (3000 g, 
12 °C, Eppendorf 5810 R, Hamburg, Germany). The remaining solution was removed 
and the protein sample was centrifuged to the desired volume.  
Table 9 outlined the concentration method, the subjacent principle of the method, required 
time and volume after treatment. All samples, including the original, were analyzed by 
SDS-gel analysis (Figure 30). 
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Method 
Aquacide Solvent absorption
Vacuum 
evaporator 
Solvent removal via evaporation
Lyophilizer* 
Dehydration process via freeze
Vacuum 
desiccator 
Dehydration via 
Vivaspin 15 Ultrafiltration via 
Table 9: Comparison of different concentration methods for FhuA 
 
Figure 30: SDS-gel of original (orig) FhuA 
concentrated with different methods: aquacide (aqua), rotary evaporator (eva), lyophilizer (lyo), 
desicator (desi), Vivaspin 15 (viva). 1.75 
lyophilized sample, 2.6 mg were solubilized in 250 
loaded onto the gel.  
 
Extraction of FhuA Δ1-159_C556_tev with 
3.5-4 mg/mL of protein. Therefore further concentration of these samples was tried. Since 
concentration via aquacide and vivaspin is fast and affordable, these methods were 
subsequently. 2 mL protein solution (buffer: 0.125 mM PE
concentration of 3.6 mg/mL were either centrifuged for 1 hour in a vivaspin ultrafiltration 
unit or put into a dialysis membrane for 20 min that was covered by aquacide (settings see 
above). Both samples were roughly 12 times concentrated, yielding arou
protein. The protein solution turned from a transparent sample into a whitish color. 
FhuA Δ1-159_C556_tev was produced in large
32). Fermentation settings were the same as for FhuA 
besides the temperature which 
Principle Time 
 via dialysis tube 40 min. 
 10 hours 
-
drying 
18 hours 
silica gel 6 days 
centrifugal force 30 min. 
Δ1-159_C556_tev.
Δ1-159_C556_tev (63.5 kDa) (abbreviated
μL of each sample were loaded onto the gel. For the 
µL A. dest, whereas 1.75 μL of the sample were 
n-hexane/ethanol/water yield
-PEG, 1mM EDTA, pH 7.5)
-scale with the Biostat ED fermenter
wildtype and FhuA
was sets to 30 °C, a starting OD600 of 0.15 
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Volume after 
treatment 
0.8 mL 
0.6 mL 
Powder  
5.2 mg 
2.0 mL 
0.5 mL 
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ed around 
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 with a 
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 (Figure 
 Δ1-159_C556, 
and induction time 
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point of OD600 1.67. Inducer concentration
3.6 x 108 cells. Cell growth was monitored (
recorded (Figure 33).    
Figure 31: SDS-gel of FhuA Δ1-159_C556_tev (63.5 kDa) 
expressed the protein after induction with IPTG. Samples (
centrifuged BI (before induction) and AI (after 
point in minutes. M = marker, SM0
 
Figure 32: OD-monitoring of 
 
 was 0.75 mM. SDS-analysis was performed with 
Figure 32) and fermentation settings were 
(abbreviated as FhuA) 
3.6 x 108 cells
induction). Small numbers display the sampling time 
671 Fermentas. 
FhuA Δ1-159_C556_tev fermentation
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fermentation. Cells 
) were taken and 
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Figure 33: Recording of FhuA Δ1-159_C556_tev fermentation settings (O2, pH, stirring rpm [stirr] and 
media-/jacket temperature [Temp]/[JTemp]). 
 
4. Discussion 
Several FhuA variants were generated (FhuA, FhuA Δ1-159, FhuA Δ1-159_S556, FhuA 
Δ1-159_C556, FhuA Δ1-159_C556_tev) and expression as well as extraction protocols were 
optimized. FhuA Δ1-159_C556_tev was finally selected to serve as a scaffold for the hybrid 
catalyst system. An overview of what has been done in terms of engineering, expression, 
extraction and purification of five different FhuA variants is given in Figure 34. Additionally, 
for each method, the amount and purity of the protein are listed.  
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Figure 34: Compilation of engineering, expression and extraction methods developed for the five 
different FhuA variants. Additionally, for each method, concentration (mg/mL), amount of extracted 
protein from one liter culture broth (mg) and purity (%) of the respective variant were listed. Empty 
areas represent that the method was not carried out while a “No” denotes that the method did not 
work for the specific protein variant. 
 
FhuA Δ1-159_S556 and FhuA Δ1-159_C556 were successfully designed, cloned, expressed 
and extracted. To develop FhuA Δ1-159_C556_tev, which is suitable for metallozyme 
approaches, a number of optimization steps were required: MD simulations to depict the 
amino acids shielding the catalyst binding position C556, calculations using FoldX plugin from 
YASARA to identify the amino acids substitutions to ensure maintenance of the stability of 
FhuA. Furthermore deletion of the His6-tag and insertion of a TEV-cleavage site were 
necessary. The latter serves to restrict the FhuA into small fragments, which is suitable for 
MALDI analysis. A synthetic gene including the mentioned substitution, insertion and 
deletion of DNA was ordered and cloned in the expression vector pPR-IBA1.  
FhuA expression always starts from with freshly transformed E. coli cells. Previous results 
from former group members showed that expression from glycerol stocks or plates stored 
longer than two weeks, in general resulted in non-reproducible protein expression. Since 
bacterial fitness is important for successful protein expression [101] and pPR-IBA1 exhibits a 
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basal expression [102], reasons for non-reproducible protein expression upon long term 
storage of the cells, could be the formation of holes in the cell membrane by any of the FhuA 
deletion variants (Δ1-159). Interestingly, expression optimization of FhuA Δ1-159_C556_tev 
showed that expression with a glycerol stock inoculated preculture is possible, resulting in 
cheaper and less work intensive conductance of the experiments. Likewise protein 
expression from a continuous culture was successful. Lower expression temperatures for 
FhuA Δ1-159_C556_tev, in contrast to the other variants, increased the probability for 
maximal productivity of the recombinant protein. Low temperature growth is associated 
with enhanced productivity, longer viability and improved production phase [103]. 
Optimization of FhuA Δ1-159 expression in different expression media, showed that FhuA 
Δ1-159 expression does not relate to the biomass amount. When E. coli grew in SOB-media, 
the culture showed an OD600 value of 3.1 and expressed FhuA reached 24-28 % of the total 
protein. When E. coli FhuA Δ1-159 grew in TY-media, the culture showed an OD600 value of 
2.4 while 35 % of the total proteins expressed were FhuA Δ1-159. Since TY-media results in 
higher expression level of FhuA, it was selected as the optimal expression media for all FhuA 
variants. Dworeck et al. [43] reported that FhuA Δ1-159 can be overexpressed in inclusion 
bodies and refolded in the polymer PE-PEG. However, signal sequence deletion of FhuA 
Δ1-159_C556 did not result in protein expression (data not shown).   
Upscaling production of FhuA variants (FhuA Δ1-159_S556 not tried) from 0.25 L (in flasks) 
to 10 L (in fermenter) was successfully performed. Further improvements need to be done 
to reduce the amount of precultures (probably achievable by small scale fermentation 
preculture). To increase cell density, regulation of pH and pO2 as well as optimization of 
temperature and fed-batch fermentation might be useful.   
SDS-gel of FhuA Δ1-159_C556 showed expressing cultures (Figure 21, S1-S5), while 
culture S6 did not express the protein. The same was observed for FhuA Δ1-159_C556_tev 
(Figure 27), S1 and S6. The plasmids of FhuA Δ1-159_C556_tev were isolated and besides a 
restriction check, plasmids were sent for sequencing and confirmed the presence of the 
respective DNA without any mutation. Since all cultures were treated the same way, 
questions arose, why the cultures did not express the protein. It is likely that over-expressed 
FhuA deletion variants are toxic for the cell since they form holes into the cell membrane, 
leading to osmotic stress of their host. Typical phenomena of handling with toxic protein are 
low yield and inconsistent expression of the protein. Growth rate, cell density problems and 
low transformation efficiency are furthermore common findings. Some bottlenecks for 
successful toxic protein expression, like adaption of plasmid amount for transformation, pre- 
and mainculture temperature and induction OD were optimized in the current study. But in 
order to get higher consistency of protein expression, one might consider helping the cells to 
express the protein by addition of transcription repressors (at the beginning of the 
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cultivation) to tightly repress the promoter or engineer a vector with additional lacI 
repressor binding sites. Low copy number plasmids or secretory expression may also support 
protein expression (personal communication to Expression Technologies Inc., PEP-TALK 
Conference, San Diego (USA), 2011).  
 
For the extraction and purification of membrane proteins, detergents, mimicking the native 
bilayer environment, play an essential role. Their amphiphilic structure, composed of a 
hydrophilic head group and a hydrophobic tail, allows them to interact with the protein and 
hence solubilize hydrophobic membrane proteins. For solubilization, a rule of thumb is to 
use a detergent concentration twice of the CMC of the detergent [104]. The CMC value 
indicates the concentration of the detergent above which monomers self-assemble into 
micelles. It depends on temperature, buffer conditions (e.g. salts) as well as on the chemical 
properties of the detergent (e.g. length of alkyl chain) [105]. Detergents can be divided, into 
three different classes according to the properties of their head groups. Nonionic detergents 
(e.g. oPOE and maltosides) are mild detergents and are able to disrupt protein-lipid and 
lipid-lipid interactions. Ionic detergents (e.g. SDS) are classified as harsh detergents. They 
efficiently disrupt inter- and intramolecular protein-protein interactions. The effectiveness of 
zwitterionic detergents (e.g. Fc-12) is between the one from nonionic and ionic detergents. 
They are electrically neutral but can disrupt protein-protein interactions [104].  
Apart from screening of the best detergent and its optimal concentration for FhuA 
extraction, one has to be aware that solubility of membrane proteins does not necessarily 
come along with structure and stability. Additionally a detergent working for one membrane 
protein may not work for a different membrane protein. Another challenge for the isolation 
of membrane proteins from lipid bilayer by detergents is the presence of mixed surfactant 
systems (here: different membrane lipids vs. the detergent) [106, 107].  
 
The standard FhuA-extraction protocol is based on the extraction of FhuA using the nonionic 
detergent oPOE. Besides the extraction of FhuA wildtype, FhuA Δ1-159 and FhuA 
Δ1-159_C556, it was also used for other reengineered FhuA variants [36, 38]. In all cases, 
extracted protein amounts were in the range of 0.3-0.6 mg/mL (equal to 4-8 mg protein 
extracted from one liter culture broth) and purity was 65-78 %. The solubilization of protein-
containing membranes by nonionic detergents can be displayed as a four step process: (a) 
the lipid phase noncooperatively takes up the detergent (b) cooperative interaction of the 
detergent leads to fragmentation of membrane sheets, but no vesicle solubilization (c) 
solubilization of small membrane sheets harboring proteins (this phase may also be referred 
as csc (critical membrane solubilizing concentration of detergent)) (d) mixture of 
lipid/detergent micelles and detergent-solubilized protein units [108]. Extraction of FhuA 
Δ1-159_S556 and FhuA Δ1-159_C556_tev with oPOE could not be achieved. Similar results 
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were observed with other engineered FhuA variants with increased channel lengths [40] or 
increased diameter [44].  
For the development of the biological part of the metallozyme, an effective extraction 
protocol, giving higher protein amounts and higher purity was essential. In the past, 
chloroform-mixtures were often used for this purpose [98, 99, 109]. The organic solvents 
solubilize membrane components with subsequent aggregation of the hydrophobic proteins. 
Using chloroform, it is known that besides membrane proteins also non-membrane proteins 
remain soluble, since the proteins are merged with lipids or contain short hydrophobic 
regions. This leads to numerous impurities that need to be removed by further purification 
steps [110]. Due to different hydrophobicity of the desired membrane protein, extensive 
screening for the specific C/water ratio is required [111]. Moreover, chloroform is as a 
halogen containing solvent harmful to health and environment. Commercially available 
green solvents like 2-MeTHF and CPME are advantageous over chloroform (no toxicity, no 
water miscibility, cheap waste treatment) and were tested for the extraction of FhuA 
Δ1-159_C556. Highest ratio of amount:purity (0.34 mg/mL – equal to 8.5 mg protein 
extracted from one liter culture broth, 95 %) was reached with 2-MeTHF/1:1 water [76]. 
Against expectation, the best water/organic solvent ratios used for the extraction of FhuA 
Δ1-159_C556, did only result in low amounts and impurities for the extraction of FhuA 
Δ1-159_C556_tev. 
 
In parallel to the organic solvent extraction, different ratios of nonionic maltoside-based 
detergents (DM and DDM) were used to extract FhuA Δ1-159_C556. These detergents are 
for example used for isolation of sugar transporter [112, 113], the leukotriene C(4) 
synthase [114] and an E. coli chloride channel [115]. Utilization of 0.5 vol% DM or DDM 
showed results comparable to the standard extraction based on oPOE, but no increased 
parameters (amount: 0.6 mg/mL, purity: 65-75 %). Additionally, the zwitterionic detergent 
Fc-12 was applied for the extraction of FhuA Δ1-159_C556. Fc-12 shows structural similarity 
to phospholipids and should therefore have high affinity towards membrane proteins. It also 
displayed good performance in the extraction of the outer membrane 
protein F (ompF) [116]. As seen in Figure 24, Fc-12 extracted the protein but various 
impurities were present.   
 
Inspired by Galanos et al. [100], who isolated polar lipids from triglyceride mixtures using 
petroleum ether, water and ethanol, a protocol for FhuA extraction was developed based on 
n-hexane/ethanol/water. Organic solvents dissolve the membrane particles including lipids, 
and precipitate the protein. Dissolving of the lipids can be reconstructed by drying of the 
organic phase. An oily, yellowish solution remains in the tube. To unfold the protein 
aggregate, urea was applied but did not result in protein solubilization. In contrast SDS, an 
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efficient anionic denaturant and solubilizing compound [117, 118], solubilized the protein 
successfully. Direct application of the n-hexane/ethanol/water-SDS method to the freshly 
obtained protein pellet (after fermentation) followed by dialysis with PE-PEG (to refold the 
protein), yielded high protein amounts (800 mg from one liter extracted culture broth) with 
only few impurities. Therefore it can be concluded that the preceding STD extraction 
solubilized undesirably proteins and lipids, leading to higher protein purity of the final 
sample.   
 
Among all the cultures for FhuA expression, some did not show any protein expression and 
some cultures showed over-expression of another protein (S7, Figure 27). In former 
studies [119], over-expression of a similar band was reported. In this case the protein was 
extracted with the conventional extraction protocol. SDS-PAGE separated the target protein 
from impurities. The 35-45 kDa protein was cut from the gel and sent for MALDI-TOF-MS 
mass analysis. With sequence identity of 72 % the protein was identified as the trimeric 
39 kDa OmpF, acting as an unspecific transporter of small hydrophilic molecules [120]. 
Contamination of OmpF in over-expression of (especially membrane) proteins has been 
recognized by others [116, 121]. Expression of OmpF is regulated as response to different 
types of stress, e.g. oxidative or nutritional [122, 123]. Microscopic analysis confirmed that 
cell shape of induced cells was altered and lower cell densities were obtained.  
 
5. Conclusion 
Genetic engineering and expression of five different FhuA variants was successfully 
accomplished. Expression conditions were optimized for TY-media, temperature (changed 
upon variant), expression starting conditions (plates/ glycerol/ continuous culture) and 10 L 
fermentation. It was found out that cultures not expressing the protein still contain the 
respective genetic information without any mutation. Overexpression of a different protein 
was related to physical stress of the cell.    
 
Different detergents (oPOE, DM, DDM, HEOS, Fc-12) were compared for protein extraction. 
Besides that extraction protocols based on organic and green solvents (chloroform, 
2-MeTHF, CPME) as well as n-hexane/ethanol/water-SDS were developed and applied, 
yielding up to 800 mg protein per liter extracted culture broth, with purity of up to 90 %. 
Unfortunately, no detergent-solvent combination was applicable for all different mutants to 
obtain the same amount and quality of the respective FhuA protein.   
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Chapter B                                                                                                             
STABILITY INVESTIGATIONS UNDER DIFFERENT CONDITIONS 
 
1. Introduction 
Electrostatic interactions, van der Waals forces, disulfide bridges and π-π stacking of 
aromatic side chains determine the overall structure of proteins [61, 124, 125]. The β-barrel 
structure of integral membrane proteins is hold together by hydrogen bonds. The rigid 
“channel-like” structure can be used as a scaffold for metallozymes or for translocation of 
molecules through artificial membranes. A common feature of β-barrel proteins is their high 
resistance towards temperature, chaotrophic salts and detergents [31]. These properties 
tremendously increase the attractivity to use these proteins as a scaffold for metallozymes. 
In order to perform reactions, catalytic activity of the hybrid catalysts needs to be 
established. This is achieved by specific coupling of a metal complex to a selected amino acid 
side chain of the protein backbone. Unfortunately, the mild reaction conditions preferred by 
the protein do not always meet the requirements of the metal complex or the reaction 
conditions. Reasons are solubility of the catalyst and the substrate that often require the use 
of organic cosolvents [2]. Additionally, certain reactions require temperature or basic/acidic 
pH conditions which are incompatible for the protein.   
So far, no systematic study regarding the structural integrity of neither a FhuA variant nor 
any other hydrophobic membrane protein in an organic cosolvent has been performed. In 
2012, the first study addressed the effect of THF, EtOH and C/M on FhuA and FhuA Δ1-159 
on the structural integrity of FhuA [46]. CD spectroscopy was selected for recording the data. 
The choice of the solvents was dictated by previous studies performed in our group, 
regarding FhuA-based triggered release systems [35, 36] and modulating compound 
fluxes [39]. Additionally, they are interesting for hybrid catalyst applications in terms of 
catalyst solubility and reaction performances [49]. A subsidiary experiment analyzed the 
performance of FhuA Δ1-159_C556 in dioxane. At that time, FhuA Δ1-159_C556 was the 
variant of choice for metallozyme generation since the ruthenium-based metal complex 
prefers either THF (which already was investigated) or dioxane for solubilization and reaction 
performances, the protein-cosolvent combination FhuA Δ1-159_C556-dioxane was selected 
for the study.  
There is no report about structural integrity analysis of FhuA at different pH values. To 
measure the structural integrity, CD spectroscopy was used. FhuA Δ1-159_C556_tev was 
investigated at pH 3, 4, 5.8, 7 and 10. Besides CD spectroscopy, structural integrity of FhuA 
Δ1-159 and FhuA Δ1-159_C556_tev in different pH values was investigated with PROPKA. 
This tool adjusts the protonation state of a protein structure to match a certain pH value.  
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The effect of temperature was already investigated in several studies. The mobility of FhuA 
and FhuA Δ021-128 after heat treatment was analyzed by polyacrylamid gel electrophoresis. 
DSC data of FhuA wildtype and FhuA Δ021-128 were published, analyzing the specific heat 
capacity of these variants in presence and absence of ferrichrome [31]. Additionally, another 
temperature stability investigation by DSC was performed with and without binding of the 
antimicrobial peptide microcin J25 to FhuA [126]. Of course, a study regarding the heat 
capacity of the initially developed FhuA variant FhuA Δ1-159_C556 or the subsequent variant 
FhuA Δ1-159_C556_tev was so far not carried out.  
This chapter should elucidate which parameter (organic cosolvents, pH and temperature) 
influence the structural integrity of FhuA and its variants.  
 
2. Stability of FhuA variants in organic cosolvents, at different pH and temperature 
2.1. Influence of organic cosolvents on FhuA, FhuA Δ1-159 and FhuA Δ1-159_C556 
Tetrahydrofuran (THF), ethanol (EtOH) and chloroform/methanol (C/M) 
The effects of organic cosolvents on FhuA wildtype and FhuA Δ1-159 were published in 2012 
in the International Journal of Molecular Sciences (doi:10.3390/ijms13022459) (see 8.1. 
or [46]).  
FhuA and FhuA Δ1-159 were expressed in TY-media in a 10 L Biostat ED fermenter from 
Sartorius (Göttingen, Germany). Cells were harvested by centrifugation and disrupted using 
a high-pressure homogenizer. Two subsequent centrifugation steps (supplementation of 
either 0.1 vol% or 3 vol% oPOE) solubilized the protein. Protein impurities were removed by 
gel-filtration (Sephadex G25-fine, GE Healthcare, München, Germany) and concentration of 
FhuA Δ1-159 was carried out with a 10 kDa centrifugal concentrator (Vivaspin 15, Sartorius, 
Göttingen, Germany). Protein purity was determined by SDS-PAGE and concentration was 
determined by the BCA-assay (Thermo Scientific, Rockford, USA). The IMAGE-J program 
showed that the purified protein samples yielded 1.3 mg/mL (FhuA) and 0.6 mg/mL (FhuA 
Δ1-159).  
For CD measurements, 0.18 mg/mL protein (leading to 20.7 μL FhuA and 45 μL FhuA Δ1-159) 
were pipetted into a small glass tube (S 4-W, transparent, Nr. 300095–100, 4 mL, 
44.5 × 14.5 mm, Chromatographie Service GmbH, Langerwehe, Germany), containing a 
stirrer (Nr. 001.106, 6 × 3 mm, Cowie, Middlesbrough, United Kingdom, stirring unit: Mot 
2.5, Ika Werke RT10, Ika Werke, Staufen, Germany). 35 % of the sample contained oPOE-
based buffer (100 mM Pi, pH 8, 1 mM EDTA, 3 vol% oPOE) whereas the remaining 65 % were 
supplemented with a mixture of the following buffer (100 mM Pi, pH 8, 1 mM EDTA) and the 
respective organic solvent (THF, EtOH or C/M (1:1 v/v) to reach 0 %, 1 %, 10 %, 25 %, 40 %, 
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50 %, 65 % (v/v) of the final solution). The buffer-organic cosolvent mixture was slowly 
supplemented by pipetting to the respective protein samples.  After 75 min incubation (RT), 
150 μL of each sample were carefully transferred with an Eppendorf pipette onto a Hellma® 
SUPRASIL cuvette (pathlength 0.5 mm, Hellma GmbH & Co. KG, Müllheim, Germany). Sample 
analysis was performed at room temperature with Olis SDM 17 CD (Olis, Bogart, USA). For 
each sample, five scans from 195 to 240 nm (increments 50, integration time 20000, 
bandwidth 2 nm, step width 1 nm) were recorded and averaged. Since addition of cosolvents 
did not significantly change the baseline of the buffer (100 mM Pi, pH 8, 1 mM EDTA, 
1.05 vol% oPOE) and additionally, deconvolution was not influenced by the presence of the 
cosolvents, their addition was neglected. Recorded CD spectra were smoothed by the 
Savitzky-Golay filter (Olis Global Works software package), and results were converted into 
mean residue ellipticity (Figure 35). Changes in the secondary structure of FhuA and FhuA 
Δ1-159, were quantified with the CONTIN algorithm [127] (Figure 35), originally developed 
by Provencher and Glockner [63] and currently implemented in the Dichroprot 
software [128]. The algorithm includes a spectra database of known secondary peptide-
structures in order to predict the content of α-helix, β-sheet and random coil in the 
respective sample (Table 10).    Jjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj 
JJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJJ                         
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Figure 35: Secondary structure of FhuA and FhuA Δ1-159 at different amounts of different organic cosolvents, measured by CD. The respective amount of 
organic cosolvent (THF, EtOH or C/M) was added to 0.18 mg/mL of FhuA or FhuA Δ1-159. After incubation, samples were analyzed and CD spectra were 
recorded (Olis spectrapolarimeter model SDM 17). Buffer baseline was directly subtracted from the sample spectra and data were smoothened (Savitzky-Golay 
smoothing filter). Data were converted into mean residue ellipticity (MRE) and fitted using the CONTIN algorithm, implemented in the Dichroprot software. 
Original data (dotted lines) and fitted data (solid lines) of (I) FhuA and (II) FhuA Δ1-159 in (a) THF; (b) EtOH and (c) C/M are shown. Samples marked with one 
asterisk showed precipitation of  FhuA  or  FhuA  Δ1-159  upon  addition  of  organic  cosolvent  which  redissolved  after incubation. Std indicates the protein in 
presence of the detergent oPOE (1.05 vol%) and phosphate buffer (100 mM Pi, pH 8, 1 mM EDTA).  Two asterisks represent FhuA or FhuA Δ1-159 precipitation 
events in which FhuA or FhuA Δ1-159 did not fully redissolve during CD measurements. (The figure was slightly adjusted from [46]). 
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Supplementation of 1-25 vol% THF or 1-10% EtOH to FhuA or FhuA Δ1-159 maintained 
transparency of the protein solution. 40 vol% THF or 25 vol% EtOH (data not shown) 
implicated in a turbid solution which disappeared after incubation (Figure 35, one asterisk). 
Further addition of these organic cosolvents was followed by constant turbidity. Addition of 
10 vol% C/M to FhuA or 1 vol% C/M to FhuA Δ1-159 resulted in similar effects (Figure 35).  
Fitting of the recorded CD data with the CONTIN algorithm resulted in similar spectra.  This 
indicates that FhuA and the variant FhuA Δ1-159 can be analyzed with this algorithm. 
Deconvolution of the spectra displayed the proposed amounts of the structural elements 
alpha-helix, β-sheet and random coil (r), of the respective protein sample (Table 10).  
 
 
Table 10: CD spectra of FhuA and FhuA Δ1-159 in the presence of varied amounts of the organic 
cosolvents THF, EtOH or C/M were recorded (mdeg) and converted into mean residue ellipticity. 
These data were fitted and deconvoluted with the CONTIN algorithm implemented in the Dichroprot 
software. The amount of α-helix, β-sheet and random coil of the respective samples was given. (The 
table was taken from [46]). 
 
Amounts of secondary structure elements, α-helix, β-sheet and random coil did not change 
significantly upon supplementation of any organic cosolvent at any concentration.  
 
Dioxane 
Stability investigations in dioxane were performed with FhuA Δ1-159_C556 (Figure 36). FhuA 
Δ1-159_C556 was expressed and extracted as described in the upper section (B.2.1.). The 
detergent used for extraction was oPOE (3 vol%). BCA-assay (Thermo Scientific, Rockford, 
USA) and IMAGE-J analysis showed that the extraction yielded 0.35 mg/mL protein. For CD 
measurements, 0.13 mg/mL protein were pipetted into a glass tube (S 4-W, transparent, 
Nr. 300095–100, 4 mL, 44.5 × 14.5 mm, Chromatographie Service GmbH, Langerwehe, 
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Germany), containing a stirrer (Nr. 001.106, 6 × 3 mm, Cowie, Middlesbrough, United 
Kingdom, stirring unit: Mot 2.5, Ika Werke RT10, Ika Werke, Staufen, Germany). 0.13 mg/mL 
protein (leading to 56 µL) in oPOE-based buffer (100 mM Pi, pH 8, 1 mM EDTA, 3 vol% oPOE) 
constitute 37 % of the sample whereas the remaining 63 % were based on a mixture of 
buffer (100 mM Pi, pH 8, 1 mM EDTA) and the respective amount of dioxane, to reach 0 %, 
25 % or 40 % (v/v) organic cosolvent of the final solution. As baseline, a phosphate-oPOE 
mixture was recorded and directly subtracted from the data (100 mM Pi, pH 8, 1 mM EDTA, 
1.1 vol% oPOE). Further sample preparation, CD settings and data analysis was performed as 
described in B.2.1.  
 
Figure 36: Structural integrity of FhuA Δ1-159_C556 supplemented with different amounts of 
dioxane, measured by CD. The respective amount of the organic cosolvent dioxane was added to 
0.13 mg/µL of FhuA Δ1-159_C556. After incubation, samples were analyzed and CD spectra were 
recorded (Olis spectrapolarimeter model SDM 17). Buffer baseline was subtracted from the sample 
spectra. Data were converted into mean residue ellipticity (MRE) and fitted using the CONTIN 
algorithm, implemented in the Dichroprot software. Original data (dotted lines) and fitted data 
(dashed/drawn lines) of FhuA Δ1-159_C556 in dioxane are presented. Std indicates the protein in 
presence of the detergent oPOE (1.1 vol%) and buffer (100 mM Pi, pH 8, 1 mM EDTA). Addition of 
25 vol% organic cosolvent leads to slight protein precipitation which redissolved after incubation. 
Addition of 40 % dioxane represents FhuA Δ1-159_C556 precipitation while the protein did not fully 
redissolve during CD measurements.       
 
Supplementation of 25 vol% dioxane during sample preparation of FhuA Δ1-159_C556 
turned the protein solution form transparent to turbid. After incubation, the turbidity 
disappeared. Addition of 40 vol% dioxane directly lead to a cloudy protein solution that did 
not clear out during incubation time (Figure 36).  
Recorded CD spectra were fitted with the CONTIN algorithm. Both spectra (recorded and 
fitted) of FhuA Δ1-159_C556 showed a similar progress in buffer (Std) and in presence of 
25 vol% dioxane. Comparison of the spectra supplemented with 40 vol% dioxane did not 
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result in similar progression. Deconvolution of the spectra predicted 0 vol% α-helix, 
65 % β-sheet and 35 % random coil for the standard protein, while in presence of 25 vol% 
dioxane, 0 % α-helix, 63 % β-sheet and 37 % random coil were obtained. Deconvolution was 
not performed in 40 vol% dioxane due to large spectral differences of recorded and fitted 
spectra of FhuA Δ1-159_C556.  
 
2.2. Influence of pH on FhuA Δ1-159 and FhuA Δ1-159_C556_tev 
FhuA Δ1-159_C556_tev was used for pH stability investigations. Starting from a glycerol 
stock, the protein was expressed in a continuous culture as described in A.3.5. The protein 
was extracted according to the protocol “Extraction protocol for FhuA and variants” 
(section 11.2., protocols), using 0.1 vol% oPOE and 0.5 vol% DDM as detergent for the first 
and second centrifugation step. Subsequently, the obtained pellet was treated with the 
organic solvents n-hexane/ethanol. SDS was used to unfold the protein while dialysis in 
PE-PEG enabled the protein to regain its natural conformation (section 11.2., protocols, 
n-hexane/ethanol/water extraction of FhuA_tev solubilization with SDS and refolding by 
dialysis). The BCA-assay yielded a protein concentration of 1.5 mg/mL. 
All samples were diluted 1:10 with buffer (0.125 mM PE-PEG, 1 mM EDTA, and 
corresponding amount of KOH to reach the final desired pH value). After 75 min incubation, 
150 µL of each sample were transferred onto a 0.5 mm pathlength Hellma® SUPRASIL 
cuvette (Hellma GmbH & Co. KG, Müllheim, Germany). Note that protein samples of pH 3 
and pH 4 were slightly turbid. For each sample, five scans were recorded with an 
Olis SDM 17 CD spectrophotometer (Olis, Bogart, USA) and averaged. The instrument 
settings were the following: scan range 190 to 240 nm, increments 50, integration time 
20000, bandwidth 2 nm, step width 1 nm. Buffer baseline (0.125 mM PE-PEG, 1 mM EDTA, 
pH 7) was directly subtracted from the spectra. The data were further analyzed by the 
CONTIN algorithm which fits the recorded spectra to a spectra database (Figure 37). 
Deconvolution was further used to determine the amount of α-helix, β-sheet and random 
coil (Table 11).  
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Figure 37: CD spectra of FhuA Δ1-159_C556_tev (0.15 mg/mL) in the respective pH values were 
recorded (Olis spectrapolarimeter model SDM 17). Samples of pH 3 and pH 4 were slightly turbid 
during measurement. The buffer baseline (0.125 mM PE-PEG, 1 mM EDTA, pH 7) was directly 
subtracted from the sample spectra. Data were converted into mean residue ellipticity (MRE) and 
fitted using the CONTIN algorithm, implemented in the Dichroprot software. Original data are 
represented as symbols, fitted data as lines/ dashed lines.  
 
pH value α-helix β-sheet Random coil 
3 1 70 29 
4 0 71 29 
5.8 0 68 32 
7 1 66 33 
10 1 66 33 
Table 11: CD spectra of FhuA Δ1-159_C556_tev in different pH values were recorded (mdeg) and 
converted into mean residue ellipticity. These data were fitted and deconvoluted with the CONTIN 
algorithm implemented in the Dichroprot software, yielding the amount of α-helix, β-sheet and 
random coil of the respective sample.  
 
CD spectra at pH 7.5 showed a maximum at around 195 nm and a minimum at around 
215 nm. Basic pH (pH 10) did not greatly alter the spectra while at pH 3 the maximum 
increased twice and at pH 3 and pH 4 the minima deviate from the original spectra. 
Deconvolution of the spectra derived from pH 7 and pH 10 showed the same amounts of 
α-helix, β-sheet and random coil. Lower pH values correlate with increased β-sheet amounts 
and decreased percentages of random coil.   
Besides analysis of pH-dependency by CD spectroscopy, computer based empirical methods 
were applied. PROPKA [129-132] uses pka-values of amino acids side chains to determine 
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pH-dependent characteristics of a protein. The pH profiles of FhuA Δ1-159 (without his6-tag 
PD-H6-DLA) and FhuA Δ1-159_C556_tev were investigated (Figure 38). 
 
 
Figure 38: pH profile of FhuA Δ1-159 (without his6-tag PD-H6-DLA) and FhuA Δ1-159_C556_tev (both 
modified from PDB entry 1BY3) analyzed by PROPKA (http://propka.ki.ku.dk/, 17.04.2012).  
 
The pH profile showed a higher stability [kcal/mol] of FhuA Δ1-159_C556_tev compared to 
FhuA Δ1-159_C556 at any pH value. Generally, PROPKA revealed that both proteins were 
most stable at physiological pH values.    
 
2.3. Influence of temperature on FhuA Δ1-159_C556 and FhuA Δ1-159_C556_tev 
FhuA Δ1-159_C556 was expressed and extracted according to the standard protocols 
(section 11.2., protocols, Expression of FhuA and variants, Extraction of FhuA and variants) 
using 3 vol% oPOE. For expression of FhuA Δ1-159_C556_tev, the protocol “Expression of 
FhuA Δ1-159_C556_tev” was applied. In case of the extraction, first the protocol “Extraction 
of FhuA and variants” (using DDM) was performed, followed by the protocol 
“n-hexane/ethanol/water extraction of FhuA Δ1-159_C556_tev solubilization with SDS and 
refolding by dialysis” (section 11.2, protocols). DSC measurements were incompatible with 
PE-PEG, therefore 1 mL FhuA Δ1-159_C556_tev was extensively dialyzed (2 x 24 h, 1 mM 
EDTA, 1 vol% oPOE, pH 7.5, volume 100 mL). 
 
Temperature stability of FhuA Δ1-159_C556 was carried out using the DSC instrument Nr. 7 
and stainless steel sample pans/covers from Perkin Elmer (Rodgau, Germany) (Figure 39). 
The temperature range was set to 20-90 °C, the heating rate was adjusted to 2 °C/min.  As 
reference 0.1 M KPi, 1 mM EDTA, 1 mM PMSF, 3 vol% oPOE, pH 7.5 (FhuA Δ1-159_C556) was 
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applied. In case of FhuA Δ1-159_C556_tev, analysis was performed with the newly arrived 
model DSC 8500 and aluminum sample pans/covers, both purchased from Perkin Elmer 
(Rodgau, Germany). The temperature range was set to 30-70 °C with a heating rate of 
5 °C/min. As reference 1 mM EDTA mixed with 1 % oPOE was applied (pH 7.5). 55.3 mg FhuA 
Δ1-159_C556 (2 mg/ mL) and 6.9 mg FhuA Δ1-159_C556_tev (4 mg/ mL) were used for 
analysis. The heat capacity of the reference sample was measured first and directly 
subtracted from the recorded sample spectra. 
 
 
 
 
Figure 39: Differential scanning calorimetry of FhuA Δ1-159_C556 (110.6 µg, stainless steel sample 
pan/cover) and FhuA Δ1-159_C556_tev (27.5 µg, aluminum sample pan/cover), recorded with the 
DSC instrument Nr. 7 (FhuA Δ1-159_C556) and DSC 8500 (FhuA Δ1-159_C556_tev) from Perkin Elmer.  
DSC analysis showed an increased temperature stability of FhuA Δ1-159_C556 compared to 
FhuA Δ1-159_C556_tev. In the first case, the protein denatures at 60.5 °C whereas the 
variant used for metallozyme applications unfolds at 54.6 °C.   
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3. Discussion 
Influence of organic cosolvents (THF, EtOH, C/M, dioxane) on FhuA, FhuA Δ1-159 and FhuA 
Δ1-159_C556  
Structural integrity of FhuA and FhuA Δ1-159 in different amounts of organic cosolvents THF, 
EtOH and C/M was verified by CD spectroscopy (Figure 35). Addition of more than 40 vol% 
THF or 25 vol% EtOH (data not shown) to any of the two variants or addition of 10 vol% C/M 
to FhuA or more than 1 vol% C/M to FhuA Δ1-159 resulted in turbid protein solutions. The 
turbidity might be caused by a local “overconcentration” of the solvents, reducing protein 
solubility. Analysis of the precipitated/aggregated particles showed that these particles 
consist of FhuA protein. The precipitate could be redissolved by supplementation of a buffer-
detergent (3 vol% oPOE) mixture or urea (4 M) and 2 h incubation time (see Supplementary 
Material [46]). This indicates that presence of detergent plays a pivotal role for water 
solubility of FhuA or FhuA Δ1-159 in the presence of organic cosolvents.  
Since CD spectra are highly dependent on protein concentration, it is assumed that 
decreased spectra intensities that were observed upon addition of increased amounts of 
organic cosolvents, are due to from precipitated/aggregated proteins. As a general trend it 
was found that the resistance of the secondary structure of FhuA proteins towards C/M is 
much lower, compared to EtOH or especially THF.  
The performed study showed that the aggregation can be divided into three-stages: 
(1) Addition of organic cosolvents only leads to slight alterations of the CD spectra. 
(2) Protein aggregation (turbid sample) occurs upon supplementation of a certain amount of 
organic cosolvent which dissolves (transparent sample) after an incubation time. It is 
assumed that the turbidity is the result of a local overconcentration of the organic cosolvent. 
Recorded CD spectra showed the typical minimum and maximum of a β-sheet peptide while 
intensity of the spectra is decreased. In stage (3), CD spectra are decreased in absolute 
values while the overall structure, typical for β-proteins, is retained. It is assumed that the 
majority of the protein precipitates while small fractions remain in solution. This hypothesis 
is further supported by deconvolution of the data. Deconvoluted spectra showed a similar 
course towards the original CD spectra. Since the course is similar, the calculated amounts of 
the secondary structure elements are assumed to be correct (Table 10).  
Besides THF, EtOH and C/M, structural integrity of FhuA Δ1-159_C556 was investigated in 
presence of dioxane (Figure 36). Data were recorded by CD spectroscopy. The CONTIN [127] 
algorithm, implemented in the Dichroprot software [128], showed that the spectra of the 
recorded data of the protein in presence of 25 vol% dioxane are in agreement with the 
predicted data. However deconvolution was not accomplished since recorded CD spectra of 
FhuA Δ1-159_C556 in presence of 40 vol% dioxane did not match to the predicted spectra. In 
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general, structural integrity of FhuA Δ1-159_C556 was higher compared to resistance of 
FhuA or FhuA Δ1-159 in C/M, while it was comparable in case of THF and EtOH.  
So far, no molecular reasons on the effects of organic cosolvents on membrane protein were 
reported. In the subsequent section protein stabilizing/destabilizing effects like water-
stripping, dielectric constant and empirical logP concept, were investigated and discussed. 
Besides that challenges of (membrane) protein spectra deconvolution are presented.  
Structural integrity of proteins is dependent on the interactions within the protein and its 
environment. Naturally, proteins operate in a water-based environment, whereas the water 
molecules are either attached to the protein via hydrogen bonds or free in solution. Water 
molecules interacting with the protein are often termed as “protein hydration shell”. 
Removal of the hydration shell e.g. by organic solvents, is associated with structural loss or 
denaturation of the proteins [133]. The interactions of organic solvents with the proteins 
surrounded by water are of great interest. But, besides three partners interacting with each 
other (protein-water-organic solvent), studying structural integrity of hydrophobic 
membrane proteins, a fourth molecule is present: the detergent. PE-PEG, oPOE, DM, DDM 
are just some examples of amphiphilic molecules used as detergents for FhuA purification. It 
is obvious that the more molecules are interacting with each other, the more complex the 
whole system will be.   
The FhuA variants display the biological entity of the system. They have three different 
regions that can interact with the solvents. The upper/lower rim of the barrel (region 1) is 
mainly hydrophilic. The intermediate part is subdivided into a hydrophobic outer part 
(region 2) and a hydrophilic inner part (region 3). The hydrophilic parts interact with water or 
the hydrophilic portion of the lipid/detergent while the hydrophobic parts interact with the 
hydrophobic portion of the lipid/detergent. 
Hydrophilic protein parts are most assailable by hydrophilic solvents because of the solvent`s 
affinity to water. Hydrophilicity is directly proportional to the dielectric constant ε of the 
donor/acceptor characteristics of the respective solvent. MeOH (ε = 33) and EtOH (ε = 30) 
are able to accept and donate hydrogen bonds to water and are therefore “dangerous” for 
the hydrophilic parts of the protein. THF (ε = 7.5) and C4H8O2 (ε = 2.3) are only H-bond 
acceptors. CHCl3 (ε = 4.8) is neither an acceptor nor a donor. According to this, MeOH and 
EtOH should have stronger effects on the protein than THF, C4H8O2 or CHCl3. But, it can 
happen that water-protein interactions are so tight that no water stripping effect of 
hydrophilic solvents can occur [134]. 
The hydrophobic part of the protein is the membrane embedded intermediate section. After 
protein extraction, the part is covered by detergent. It consists of 45.4 % hydrophobic 
residues [30]. The logP value, which is often described as a measure of lipophilicity, was used 
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to investigate the interactions of the solvents with the hydrophobic part. The logP value of 
CHCl3 is 2.0, THF = 0.53, EtOH = -0.24, C4H8O2 = -0.27 and MeOH = -0.76. Higher logP values 
describe higher lipophilicity and therefore less harmfulness to the hydrophobic protein 
parts. The impact of interactions of CHCl3, THF, EtOH, C4H8O2 and MeOH towards the 
hydrophilic/hydrophobic parts of FhuA Δ1-159 are described in relation to the dielectric 
constant and logP concept of these solvents (Figure 40).   
 
Figure 40: Schematic representation of the “aggressiveness” of MeOH (methanol), EtOH (ethanol), 
THF (tetrahydrofuran), chloroform and dioxane towards the hydrophilic/hydrophobic parts of FhuA 
Δ1-159. The hydrophilic protein parts (upper/lower rim) are “vulnerable” by hydrophilic solvents 
whereas hydrophilicity can be described by the dielectric constant. Hydrophobic part (intermediate 
section) interactions can be indicated by the logP values. 
 
The approach to understand the structural integrity of membrane proteins in presence of 
organic cosolvents by the dielectric constant and logP concept, simplifies the model but still 
it does not answer all open questions. Fortunately, the general trend of higher stability in 
THF compared to EtOH seems to be explainable by these parameters. Dioxane is favored by 
the hydrophilic proteins parts while it is “out-of-favor” by the hydrophobic parts. Therefore 
it is difficult to analyze the interactions. In case of C/M mixture, they should affect the 
protein stability in a comparable manner as dioxane because MeOH is unfavorable by the 
hydrophilic and hydrophobic protein parts while chloroform should be accepted from both 
parts of the protein. The question came up, why does the C/M mixture directly lead to 
protein aggregation? So far, the detergent oPOE which surrounded the hydrophobic parts of 
the protein was not taken into account. Therefore, oPOE solubility in varied concentrations 
of the cosolvents THF, EtOH and C/M was investigated (see Supplementary Material [46]). 
Dioxane was excluded because stability test of FhuA Δ1-159_C556 were only performed with 
two concentrations, in a non-systematic manner. THF and EtOH could be mixed with 3 vol% 
oPOE without showing changes in turbidity. Addition of 3 vol% oPOE to C/M directly resulted 
in a turbid solution that became clear over time while “lipid-like” droplets were still visible. 
Therefore it was concluded that the mixture of C/M does not directly affect the protein 
stability by interactions with the protein but it interacts with the detergent. This interaction 
leads to “detergent-stripping” which came along with protein aggregation.  
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In the subsequent paragraph, interactions between the organic cosolvents, water and the 
protein will be discussed on a molecular level.  
Addition of THF to water leads to H-bond formation between THF and water. The THF 
molecule will be encapsulated by the water molecules. Upon further supplementation of 
THF, competition of THF O-atoms for H-bond formation increases [134]. The study suggests 
that this leads to disruption of the water surrounding the protein and only minor changes in 
protein structure occur. Up to 0.2-0.4 mole fraction THF (53-73 %), O-atoms of THF do not 
efficiently compete as hydrogen bond acceptors. They prefer THF-THF interactions [135]. 
H-bonds between the water molecules will be replaced by H-bonds between THF and water 
at 0.4-0.7 mole fraction (73-90 %). Water molecules will rearrange around the protein due to 
competition with THF molecules, leading to protein precipitation [134].  
Protein structure in presence of EtOH showed greater discrepancies compared to THF. 
Roughly 20 water molecules mainly interact with the methyl group of EtOH, forming a 
distorted cage around EtOH [136]. Increased EtOH concentrations lead to H-bond 
competition of the hydroxyl group of EtOH and van der Waals interactions with the alkyl 
chain. The rearrangement of the water accompanies rearrangement of the detergent, 
resulting in decreased protein solubility and aggregation.  
Addition of dioxane to water breaks the water cluster step by step. The water molecules 
rearrange and form a micel-like cluster around dioxane molecules. It was investigated that 
0.83 mole fraction dioxane (95 %) result in an ordered, stable structure. This structure is 
cyclic with five water molecules surrounding one dioxane molecule [137]. In case of FhuA 
Δ1-159_C556 structural changes were observed above 25 vol% dioxane.  
The proteins were least stable in C/M mixtures. The chlorides van der Waals dimension 
minimizes the H-bond donor characteristics of chloroform. As observed in turbidity 
experiments of oPOE and chloroform, it is most likely that these interactions lead to 
“detergent-stripping”. MeOH now has “easier” access to the water molecules surrounding 
the protein and the H-bonds of the protein itself. The interaction promotes FhuA 
precipitation.  
It is not easy to characterize structural integrity of a system composed of a biomolecule 
surrounded by detergent, encapsulated in water/organic cosolvent mixtures since many 
different starting points to interpret the results, exist. Nevertheless, the study revealed that 
FhuA has a high stability in presence of organic cosolvent mixtures like THF, EtOH and 
dioxane. Stability and secondary structure content are not simply proportional to the organic 
cosolvent concentrations but show a complex folding-unfolding behavior.  
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As part of the folding and unfolding behavior of membrane proteins, analyzed by CD 
spectroscopy, challenges in deconvolution of CD spectra will be discussed.  
The origin and number of the spectra in the reference data-set are crucial in order to select 
the right deconvolution method [138]. So far, different methods were applied, all of them 
yielded different amounts of β-sheet content. Secondary structure assignment of the 
wildtype (PDB entry 2FCP) revealed 49 % β-sheet content [29], DSSP exhibited 53 % [139], 
while the Andrade algorithm predicted 51 % [33]. Besides that, variations in the β-sheet 
content were observed when the same protein was analyzed with the same algorithm. An 
example is FhuA Δ1-159 which was investigated with the CONTIN algorithm [127]. β-sheet 
contents of 60-65 % were calculated [43].  
Besides choosing the right deconvolution method, sample preparation and protein “purity” 
must be included for data evaluation. For instance, β-sheets contribute four times less to CD 
spectroscopic analysis compared to α-helical structures [71]. Furthermore, a higher 
structural flexibility of β-strands (sheets, propellers, barrels, β-helices) can be observed [70]. 
Analysis of secondary structure by CD spectroscopy was originally developed for soluble 
proteins. In terms of hydrophobic membrane proteins one always has to tackle with the 
presence of detergents that, depending on their origin and concentration, can shift the 
wavelength [43, 140]. Dworeck et al. [43] investigated a blue shift in presence of the 
polymer PE-PEG. In case of solvents, red- (apolar solvents) and blue-shifts (polar solvents) 
were reported [138].   
 
Influence of pH on FhuA Δ1-159 and FhuA Δ1-159_C556_tev  
Diels-Alder reactions occur at physiological pH conditions. Therefore pH stability studies of 
FhuA for this particular reaction are not essential. However, current studies investigate FhuA 
to be used as a platform catalyst (different metal complexes will be coupled to FhuA in order 
to catalyze different reactions). Some of the possible reactions, e.g. metathesis reaction 
showed highest turnover number at pH 2 [59]. It is important to find out the stability 
benchmark for the FhuA protein. In this perspective, unfolding of FhuA Δ1-159_C556_tev at 
different pH values was monitored by CD (Figure 37). CD spectra at pH 7.5 showed the 
typical structure of a protein rich in β-sheets. Basic pH (pH 10) did not greatly alter the 
spectra while at pH 3, pH 4 and pH 5.8 the characteristic minimum and maximum deviate 
from the original spectra. The breakage of H-bonds might be one reason for low stability in 
acidic environments. It was concluded that reactions occurring at physiological and basic pH 
values are highly preferred over acidic pH values. The changes were in agreement with 
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deconvolution data (Table 11). But, as discussed before, deconvolution data obtained from 
proteins that partially precipitate in sample preparation, have to be analyzed carefully.  
Additionally to CD analyzes, the structures of FhuA Δ1-159 and FhuA Δ1-159_C556_tev were 
investigated by a computer based method (PROPKA) that uses empirical parameters to 
estimate pka-values of amino acid side chains to predict protein stability (Figure 38). The 
tool considers contribution of H-bond formation, charge interactions and desolvation. The 
method was developed for water soluble proteins and unfortunately it does not take into 
account the membrane/detergent shell that stabilizes the protein. However, even in absence 
of the protecting environment, a stability trend can be observed. Figure 38 showed that 
FhuA Δ1-159_C556_tev has, especially between pH 4 and pH 10, increased stability over 
FhuA Δ1-159. The only differences between the two variants are two additional recognition 
sites for tev-cleavage (ENLYFQG) located at the surface exposed loops of FhuA 
Δ1-159_C556_tev. These extra amino acids, or particularly E, L and T with side-chain 
pka-values of 4.25, 10.53 and 10.07 [141] seem to contribute to enhanced stability between 
pH 4 and pH 10.5. As conclusion, PROPKA cannot simply be applied for pH-dependent 
stability tests of membrane proteins, but it can help to gain further insights to understand 
the unfolding of these proteins.   
 
Influence of temperature on FhuA Δ1-159_C556 and FhuA Δ1-159_C556_tev  
Temperature stability of FhuA Δ1-159_C556 (60.5 °C) was higher compared to FhuA 
Δ1-159_C556_tev (54.6 °C) (Figure 39). The data are in agreement with data obtained by 
Bonhiver et al. [31] who analyzed a FhuA deletion variant (Δ021-128, in buffer containing 
0.05 % LDAO) and recorded a melting point of 61.6 °C. The investigated wildtype showed 
two peaks at T1 65 °C and T2 74.4 °C which most probably are related to the unfolding of the 
cork domain (T1) and the barrel (T2). Less stability of FhuA Δ1-159_C556_tev compared to 
FhuA Δ1-159_C556 can be explained by removal of the salt bridge between E512***N559. 
Furthermore, extraction of FhuA Δ1-159_C556_tev was slightly different (FhuA 
Δ1-159_C556_tev standard extraction with 0.1 vol% oPOE and 0.5 vol% DDM with 
subsequent organic solvent extraction n-hexane/ethanol/water-SDS and dialysis against 
1 vol% oPOE; FhuA Δ1-159_C556 standard extraction with 0.1 vol% oPOE and 3 vol% oPOE) 
which could result in different denaturation temperatures. Furthermore, 1 vol% oPOE is 
much closer to the CMC of oPOE compared to 3 vol% which also could have an effect on 
stability of the protein [142].  
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4. Conclusion 
Different conditions (addition of organic cosolvents, pH variation and melting point 
determination) were applied to investigate the stability of different variants of the 
membrane protein FhuA. It was found out that FhuA as well as FhuA Δ1-159 are structural 
intact in up to 40 vol% THF and 10 vol% EtOH. In C/M mixtures, FhuA aggregates, above 
10 vol% of organic cosolvent. FhuA Δ1-159 already indicates strong aggregation above 
1 vol% C/M. CD spectra of FhuA Δ1-159_C556 treated with up to 25 vol% dioxane showed 
structural integrity of the protein. Independent of the structural integrity of all three variants 
treated with any of the four organic cosolvents/ cosolvent mixtures, deconvolution of CD 
spectra showed that even at high concentrations of organic cosolvent, the protein structure 
did not greatly alter the examined structure. It was found out that the cork domain improves 
the resistance of FhuA in organic cosolvents and that the detergent plays a pivotal role in 
stabilizing the protein structure.  
pH stability investigations of FhuA Δ1-159_C556_tev demonstrated that physiological and 
basic pH values are preferred over acidic pH values. Reasons for this could be the breaking of 
hydrogen bonds, especially at the inserted TEV-cleavage sites, which break at acidic 
pH values. 
Denaturation of the protein investigated by DSC measurements showed increased stability 
of FhuA Δ1-159_C556 compared to FhuA Δ1-159_C556_tev. The amino acid sequence of 
FhuA Δ1-159_C556_tev is very similar to FhuA Δ1-159_C556, but removal of the salt bridge 
(E512***N559) could lead to decreased stability. Furthermore, the proteins were extracted 
by different methods and were surrounded by different concentration of oPOE.  
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Chapter C                                                                                                              
STEPS TOWARDS THE METALLOZYME 
 
1. Introduction 
As discussed in the beginning of this doctorial thesis, the scope of catalytic reactions 
performed with metallozymes increased tremendously within the last couple of years. This is 
especially based on the variety of scaffolds and catalysts that can be used. But so far no 
membrane protein was applied as a scaffold. We assume that the characteristics of 
membrane proteins (see 2.2.) can broaden the application of metallozymes. Therefore, FhuA 
as a representative of a highly hydrophobic β-barrel protein was selected to perform 
coupling with a Ru-based metal catalyst. This doctorial thesis displays a proof of concept for 
the development of a metallozyme based on a membrane protein scaffold. Some months 
ago, on the basis of the herein presented results, further chemogenetic modification on the 
catalyst and the protein were performed in order to set-up a “platform catalytic system”.   
In chapter A and B, production and characterization of the scaffold was reported. The 
Ru-catalyst, representing the catalytic moiety of the metallozyme, was synthesized and 
characterized by collaborators in the group of Prof. Okuda (Institute for Inorganic Chemistry, 
RWTH Aachen University). A short summary of the synthetic pathway of the Ru-catalyst is 
provided in chapter C. Besides that, chapter C focuses on the production of the scaffold, 
assembly of the catalyst and the protein, analysis of the structural integrity of the system by 
CD, as well as on the proof of coupling by cysteine-titration and MALDI-TOF-MS.  
 
2.  Scaffold and metal catalyst preparation (including MD simulations of metal-
protein coupling) 
For protein production, sterile tooth picks were dipped into a glycerol stock of E. coli omp8 
cells containing fhuA Δ1-159_C556_tev-pPR-IBA1 and each of them was thrown into 20 mL 
LB(A) (100 mL Erlenmeyer flask). The cells grew for 18 hours at 30 °C (250 rpm). The cultures 
were combined and the respective volume of preculture was used to inoculate the 10 L 
Biostat ED fermenter (TY(A)) with an initial OD600 of 0.15. The fermenter settings were 
adjusted to 150 rpm and 30 °C. Additionally, the fermenter was sparged with air. At 
OD600 1.7, sterile IPTG (0.75 mM) was supplemented to start protein expression. After 
10 hours of fermentation, OD600 was around 3.0 and the cells were harvested (4000 rpm, 
20 min, 4 °C, Eppendorf 5810 D, Hamburg, Germany). The obtained pellet was extracted 
according to the standard extraction protocol (section 11.2., protocols, Extraction of FhuA 
and variants). Instead of the detergent oPOE, 0.1 vol% DDM in a first and 0.5 % DDM in a 
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second step were applied. The pellet was subsequently treated with n-
hexane/ethanol/water, SDS and PE-PEG to disrupt the membrane, solubilize and 
subsequently refold the protein (section 11.2., protocols, n-hexane/ethanol/water extraction 
of FhuA Δ1-159_C556_tev solubilization with SDS and refolding by dialysis). Figures related 
to the expression and extraction can be found in chapter A.3.5. 
The synthesis of the [Ru-Cp*] catalyst is based on the publications of the group 
of Maitlis [54-57] for ring-methyl activation in pentamethylcyclopentadienyl complexes. 
Synthesis of the complex is shown in Figure 41 while synthesis of the maleimide linker 
function (for the anchoring of FhuA Δ1-159_C556_tev to the catalyst) is presented in Figure 
42. Bold numbers in the subsequent paragraph refer to the synthesis steps of Figure 41 and 
Figure 42 respectively.  
Pentamethylcyclopenta-1,3-diene 1 (synthesized according to [143]) and ruthenium (III) 
trichloride hydrate 1 (Merck, Darmstadt, Germany or ABCR, Karlsruhe, Germany)  were used 
as starting material, for the synthesis of the dimeric tetramethylfulvene complex 2, a brown 
air sensitive compound. The complex was briefly treated with oxygen and subsequent slow 
bubbling of CO gas through the reaction solution furnished the air. A moisture stable 
complex 3 in good yield was obtained. During the aforementioned process the chloride 
undergoes a nucleophilic attack on one of the methyl groups of the cyclopentadiene which 
results in a functionalised Cp*-ring. In order to attach the linker unit on the Cp*-ring, the 
chloride was exchanged by an alcohol function by treatment of 3 with a base (2,3,4-collidine) 
and water. Esterification of the obtained complex 4 with the acid chloride of the linker 5 
provided the desired ruthenium complex [Ru-Cp*] 6. This complex includes a maleimide 
linker function for anchoring of the complex to the thiol group of FhuA Δ1-159_C556_tev. 
 
4 EXPERIMENTAL CHAPTER C: Steps towards the metallozyme 
73 
 
 
Figure 41: Synthesis of the [Ru-Cp*] catalyst. 
 
The linker unit 5 has been prepared according to literature [144]. Starting from maleic 
anhydride 7 and 4-aminobutyric acid 8, the acid 9 was obtained. The reaction of 9 with 
thionyl chloride delivered the desired linker 5 in good yield. 
 
Figure 42: Linker synthesis. 
 
Detailed information on the synthesis of [Ru-Cp*] and the maleic linker can be obtained 
from Professor Okuda`s group (Institute for Inorganic Chemistry, RWTH Aachen University). 
 
 
 
Metal-protein coupling including Yasara analysis 
The coupling strategy of [Ru-
coupling (Figure 43). The maleimide represents the linking unit of the catalyst. Its double 
bond reacts with the thiol group found in cysteine (C556) of the protein backbone, forming 
stable carbon-sulfur bonds [145]
(see C.3.1.).  
Figure 43: [Ru-Cp*] coupled to cysteine C556 of the protein backbone via maleimide
 
Determination of possible orientation of [Ru
Δ1-159_C556_tev upon coupling were analyzed with Yasara (Version 12.4.18)
Force field Amber03 and the general amber force field (GAFF) were applied to minimize the 
bond stretching energy of the molecules and facilitate ligand
the simulations, the metal ruthenium was exchanged by iron due to absence of r
the Yasara program. To avoid atom loss during simulation, distance constraint of Fe
were set to 2.2 Å and distance constraint of H
was set to zero (carbons of Cp* (C14, C15, C16, C17, C18) = 
carbons of Cp* (C13 = -0.16, C20 = 
energies (798 kJ/Mol) were obtained by 
position 504 of the protein backbone
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Figure 44: Yasara analysis of [Fe-Cp*] (dark grey) coupled to cysteine at position 556 (turquoise) of 
the protein backbone. The most probable orientation of Cp* within the protein backbone of FhuA 
Δ1-159_C556_tev is a π-π stacking of Cp* with the protein`s phenylalanine at position 504 (light 
grey). Left – top view, right – side view, lower figure – side view with zoom.  
 
3. Coupling strategy and proof of coupling 
3.1. Coupling strategy 
In the first approach, the dialyzed protein was used for coupling of the [Ru-Cp*] complex. 
Due to precipitation of the protein, the coupling was performed in presence of 1 % SDS. 
Since after n-hexane/ethanol extraction the protein was already in 1 % SDS, this sample was 
used for coupling of the metal complex. After coupling, the metallozyme was refolded by 
dialysis.  
The total volume for each set-up was 2 mL. 1.99 mL protein were filled into a small glass 
tube (14.7 mL volume, 55 x 17 mm) standing on a magnetic stirrer (stirring magnet: 
Nr. 001.106, 6 × 3 mm, Cowie, Middlesbrough, United Kingdom, stirring unit: Variomag 
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Electronicrührer Multipoint HP, 300 rpm, 2mag-USA, Daytona Beach, Florida, USA). The 
amount of FhuA Δ1-159_C556_tev was determined by the BCA-assay (Pierce Chemical Co, 
Rockford, USA) and yielded between 40-60 µM. The amount of [Ru-Cp*] (509 g/mol) which 
was dissolved in pure THF (0.01 mL) was five times the molarity of FhuA Δ1-159_C556_tev 
(ratio FhuA Δ1-159_C556_tev:[Ru-Cp*]  1:5). Finally, the [Ru-Cp*]-THF mixture was slowly 
added by pipetting to the protein solution. The final THF amount was 0.5 vol%. The 
supplementation of the [Ru-Cp*]-catalyst turned the FhuA Δ1-159_C556_tev/solvent 
solution from transparent to slightly turbid. After 24 h stirring at RT, the sample was filled 
into a dialysis membrane (MWCO 12-14 kDa, Spectral/POR, Spectrum Laboratories, 
California, US) and dialyzed twice for 24 h in 200 mL buffer (0.125 mM PE-PEG, 1 mM EDTA, 
pH 7.5). The sample, which meanwhile is transparent again, was transferred into a tube and 
centrifuged (20 min, 4000 rpm, 15 °C, Eppendorf 5810 R, Hamburg, Germany). It should be 
noted that ratios of FhuA Δ1-159_C556_tev:[Ru-Cp*] and concentration of THF were 
optimized towards minimal protein turbidity during coupling.  
 
3.2. Cysteine titration 
The efficiency of [Ru-Cp*]-coupling was determined by a fluorescence assay based on the 
fluorescence generated by ThioGlo1 (595501-5MG, Merck, Darmstadt, Germany). The dye 
reacts with active –SH groups of proteins [147]. It can be concluded that high fluorescence 
values derive from less efficient catalyst coupling, while low values indicate successful 
coupling. Advantages of ThioGlo1 over other thiol reagents are among others, its high 
fluorescence after coupling with –SH, very low fluorescence of unreacted ThioGlo1, fast 
reaction and minimal photobleaching. A stock solution (300 µM) was prepared in acetonitrile 
and stored at -80 °C. In order to determine the coupling efficiency, 50 µL of the coupled 
sample were mixed with 50 µL buffer (0.125 mM PE-PEG, 1 mM EDTA, pH 7.5) and 20 µL 
ThioGlo1 in a 96-well microtiterplate (Nr. 655900, Greiner Bio One, Frickenhausen, 
Germany). After 30 min at RT, the fluorescence intensity was measured (excitation 379 nm, 
emission 510 nm, Tecan i-control, Infinite 200Pro, Männedorf, Switzerland) (Figure 45).  
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Figure 45: Fluorescence intensity measurements of FhuA Δ1-159_C556_tev (abbreviated as FhuA) 
after coupling to ThioGlo1. FhuA Δ1-159_C556_tev-[Ru-Cp*] (abbreviated as FhuA-Cp*) represents 
the sample in which the protein was coupled to the metal complex [Ru-Cp*] (ratio 1:5). Coupling 
occurred in the respective amounts of THF (20 vol%, 0.5 vol%, no THF). The fluorescence intensity of 
the baseline (0.125 mM PE-PEG, 1 mM EDTA, pH 7.5) was directly subtracted from the data. Data of 
FhuA in presence of 20 vol% THF were similar to values obtained for FhuA (control data not shown).  
 
Highest fluorescence intensity was obtained from the pure protein sample (Figure 44). The 
intensity decreased if the catalyst was coupled to the protein, regardless of the amount of 
THF used for coupling. Lowest values were obtained from no THF < 0.5 vol% THF < 20 vol% 
THF.  
 
3.3. Circular dichroism 
To analyze structural integrity of FhuA Δ1-159_C556_tev after coupling to [Ru-Cp*], CD 
measurements were performed. First, three spectra of the catalyst solution (300 µM in 
0.125 mM PE-PEG, 1 mM EDTA, 33 vol% THF, pH 7.5, 150 µL) were recorded from 
190-240 nm using a 0.5 mm pathlength quartz cuvette from Hellma (Hellma GmbH & Co. KG, 
Müllheim, Germany) (Figure 46). Sample analysis was performed at room temperature with 
Olis SDM 17 CD (Olis, Bogart, USA). The CD settings were: bandwidth 2 nm, step width 1 nm, 
increments 50, integration time 20000, recorded unit (mdeg).  
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Figure 46: CD spectra of [Ru-Cp*] (300 µM) in buffer containing 33 vol% THF (0.125 mM PE-PEG, 
1 mM EDTA, pH 7.5). Three scans (1, 2, 3) were recorded in millidegree (mdeg) from 190-240 nm.  
 
Due to high signal/noise ratios with tremendous variations in the range of 190-195 nm, the 
benchmark wavelength to analyze the protein samples was set to 200 nm. In case of the 
protein samples, five scans for each of the FhuA sample were recorded (Figure 47). The 
spectra of the same sample were averaged and the respective baseline was subtracted. The 
investigated controls were: extracted and dialyzed FhuA and as well as extracted, 20 vol% 
THF exposed and dialyzed FhuA. For the coupled samples, coupling conditions with no 
cosolvent, 0.5 vol% or 20 vol% THF were performed. The ratio of FhuA 
Δ1-159_C556_tev:[Ru-Cp*] was 1:5. For all analysis, the protein was diluted with buffer 
(0.125 mM PE-PEG, 1 mM EDTA, pH 7.5) to 0.36 mg/mL, total volume 150 µL.  
 
4 EXPERIMENTAL CHAPTER C: Steps towards the metallozyme 
79 
 
 
Figure 47: CD spectra of different samples of FhuA Δ1-159_C556_tev (abbreviated as FhuA, 
0.36 mg/mL), recorded in millidegree (mdeg). The first sample (FhuA) represents the protein after 
n-hexane/EtOH/SDS extraction and refolding (0.125 mM PE-PEG, 1 mM EDTA, pH 7.5). The second 
sample (FhuA THF 20 %) describes the protein which after organic solvent extraction (buffer 
composition: 1 vol% SDS, 0.125 mM PE-PEG, 1 mM EDTA, pH 7.5), was treated with 20 vol% THF 
(24 h, RT). Subsequently the sample was dialyzed (2x 24 h, 0.125 mM PE-PEG, 1 mM EDTA, pH 7.5). In 
case of FhuA Δ1-159_C556_tev coupled to [Ru-Cp*] (ratio FhuA Δ1-159_C556_tev:[Ru-Cp*] 1:5), the 
coupling occurred after n-hexane/EtOH/SDS extraction in presence of 1 vol% SDS (in 0.125 mM 
PE-PEG, 1 mM EDTA, pH 7.5). The respective amount of THF was used for coupling (20 vol%, 0.5 vol%, 
no THF – 24 h, RT) and the samples were dialyzed against buffer (2x 24 h, 0.125 mM PE-PEG, 1 mM 
EDTA, pH 7.5). They were diluted to the desired concentration using the same buffer (0.125 mM 
PE-PEG, 1 mM EDTA, pH 7.5) and measured by CD.  
 
FhuA Δ1-159_C556_tev (here: FhuA), showed the typical structure for β-barrel proteins with 
a minimum around 215 nm and a maximum around 195 nm (maximum can only be 
estimated due to benchmark wavelength of 200 nm). The CD spectra of the protein and the 
protein coupled to the catalyst [Ru-Cp*] are almost identical. FhuA Δ1-159_C556_tev in 
presence of THF, regardless if it is coupled or not, demonstrated the same shape of the CD 
spectra but the minimum was decreased.  
 
3.4. MALDI-TOF-MS analysis 
The method was established for FhuA Δ1-159_C556. The first drawback was that mass 
detection of the whole FhuA Δ1-159_C556 protein was not possible. This is most probably 
due to the hydrophobicity of the protein which makes it difficult for the protein to get 
ionized [148]. Protein digestion with AspN or GluC did also not lead to the desired results.  
Two tev-protease (tobacco etch virus) cleavage sites (besides two mutations, E512F, N559V 
in amino acid sequence and deletion of the his6-tag (PD-H6-DLA)) were introduced on the 
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extracellular loop 7 and 8 of FhuA Δ1-159_C556. The synthetic gene of the new variant was 
ordered and named FhuA Δ1-159_C556_tev. For cleavage (Table 12) of the protein into 
three pieces, roughly 40 kDa, 17 kDa and 6 kDa in size (Figure 48), FhuA Δ1-159_C556_tev-
[Ru-Cp*] was incubated with the tev-protease for 24 h at RT. The protease was kindly 
provided by A. Shehzad (Institute of Biotechnology, RWTH Aachen University). It was self-
prepared using affinity chromatography over Protino Ni-IDA columns. The storage buffer was 
50 mM Tris-HCl, 1 mM EDTA, 5 mM DTT, 25 % v/v glycerol, 0.1 % w/v Triton X-100, pH 7.5. In 
order to check whether restriction was successful, before continuing with MALDI analysis, 
the samples were visulized on SDS-gel (Figure 49).  
Volume Composition 
3 µL DTT (0.1 M) 
7 µL 
20x Tev-buffer 
(1 M Tris-HCl, pH 8.0, 10 mM EDTA) 
20 µL (1.3 U/µL) tev-protease 
90 µL 
Coupling sample FhuA Δ1-159_tev-
[Ru-Cp*] 
Table 12: Enzymatic digestion of FhuA Δ1-159_C556_tev using tev-protease. 
 
 
Figure 48: Cut out of the amino acid sequence of FhuA Δ1-159_C556_tev. Tev-cleavage sites 1 and 2 
(red) within the extracellular loop 7 and 8 and resulting fragment 1, 2 and 3 after protease cleavage 
are shown. The protease cuts between Q and G (indicated by Q.G). Fragment 2, containing C556 
(blue) is detected by MALDI-TOF-MS. Orange amino acids (F, V) illustrate the exchanged amino acids 
for better catalyst binding.  
Figure 49: SDS-gel of FhuA Δ1
tev-protease (protease is visible at 27 kDa)
(baseline, no catalyst [Ru-Cp*] (abbreviated as
Cp* represent the amount of THF used for catalyst coupling (ratio 1:5, Cp*:protein). Cp* stands for 
coupling of the catalyst [Ru-Cp*] 
fragment 3 (circa 17.2 kDa) display the two bigger FhuA fragments after digestion. (Fragment 
5.9 kDa) cannot be seen on the gel). 
 
For MALDI analysis, the coupled, successfully restricted 
samples were desalted and concentrated with ZipTip C18 (Millipore, USA)
spotted on Prespotted AnchorChip targets (Bruker Daltonics, Bremen, 
the prespotted dihydroxy benzoic acid
spots. The MALDI-TOF-MS analyses 
with an Ultraflex III TOF/TOF mass spectrometer (Bruker Daltonics, Bremen, Germany)
cooperation with Dr. M. Brocker, I
background noises from the undigested protein sample
protein sample (control) with a mass of 5908
peak at 6418 (protein fragment 
break during ionization of the samples in the MALDI instrument, 
fragment 2 + linker) or 6091 (protein fragment 
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Figure 50: MALDI-TOF-MS analysis of different FhuA Δ1
protein, the digested (tev-protease) 
afterwards as well as the digested protein, coupled to 
0.5 % THF (subsequent dialysis) were investigated. Additionally, a detail
mass/charge of 5700-6600 of the last sample is given. 
 
Mass spectrometry of undigested 
at 9128 (Figure 50), which was also present in all other samples. Besides this signal, no other 
protruding peak could be observed. The protein, 
a small peak at 9129, a high mass peak at 5909
smallest fragment obtained after tev
used for coupling. Coupling of the
digestion with tev-protease exhibited a huge peak at 6092 and a small one at 9128. 
peak at 6092 Da shows binding of the catalyst to the protein. 
Δ1-159_C556_tev-[Ru-Cp*] hybrid 
the linker attached to the protein was detected. Higher resolution of the 6092 mass peak 
showed that several peaks are present. The first 
Δ1-159_C556_tev, on which the 
peak (6105, not labeled) correlates 
protein.  
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4. Discussion 
The experimental chapter C described the steps towards the successful development of a 
metallozyme made of a [Ru-Cp*] metal complex coupled to the protein FhuA 
Δ1-159_C556_tev. The biological and chemical moieties of the system were developed 
separately. Analysis of the coupling was performed by cysteine-titration and MALDI mass 
analysis. Structural integrity of the protein after coupling was inquired by CD.  
The fluorescence dye ThioGlo1 specifically binds to free –SH groups, resulting in increased 
fluorescence [147]. FhuA Δ1-159_C556_tev exhibits one free cysteine at position 556 which 
is used for coupling of [Ru-Cp*]. Reaction of ThioGlo1 with the uncoupled protein lead to 
increased fluorescence intensity, compared to the reaction of ThioGlo1 with the protein 
coupled to the catalyst (Figure 45). In this case, the binding site (C556) of the coupled 
protein was occupied by the metal complex. To find out the best coupling conditions, the 
coupling was performed in presence of varied amounts of THF. Cysteine titration of the 
coupled samples showed that 0 vol% and 0.5 vol% revealed a comparable coupling efficiency 
(low fluorescence).   
The CD spectra of FhuA Δ1-159_C556_tev with/without THF coupled to [Ru-Cp*] as well as 
uncoupled were alike (Figure 46). They all exhibit the β-sheet characteristic minimum of 
around 215 nm. Peak variations are due to β-turns or antiparallel interactions between the 
β-sheets likewise as α-helical contributions [70] (FhuA is not a pure β-sheet protein, α-helix 
content around 10 %). Unfortunately, the β-sheet characteristic maximum of 195 nm could 
not be measured because of the existence of UV absorbing compounds of the metal catalyst 
(Figure 46). Therefore, measurements were performed from 200-240 nm. Differences of the 
intensity of the minimum between the spectra with and without THF can be caused by 
protein precipitation. CD-spectra intensity is highly dependent on the protein 
concentration [149]. Before coupling of the catalyst to the protein, the protein concentration 
was determined with the BCA-assay. After coupling, the protein concentration could not be 
determined any more due to presence of the catalyst and possible remaining of THF. No 
linear, reproducible dependency of catalyst ratio and protein concentration could be 
determined.  
MALDI analysis of [Ru-Cp*] coupled to FhuA Δ1-159_C556 showed that the whole protein is 
not detectable by MALDI (Figure 50). It is widely known that ionization efficiency is lower for 
hydrophobic proteins due to presence of detergents [148] and their tendency for 
self-aggregation [80]. Protein digestion with trypsin is difficult due to low abundances of 
trypsin cleavage sites [81]. Digestion with AspN or GluC did not lead to the desired results 
either. Introduction of two tev-cleavage sites to the external loops of FhuA Δ1-159_C556, 
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leading to the new variant FhuA Δ1-159_C556_tev, finally, after protein cleavage, resulted in 
detection of fragment 2 (calculated molecular mass 5.9 kDa) which exhibits the catalyst 
binding site. MALDI analysis displayed a mass of 5908 Da, which is due to different 
composition of the residues, e.g. addition of hydrogen [89]. Ionization strengths of MALDI 
are strong and therefore it was taken into consideration that the metal containing part of 
the catalyst might be separated from the linker. Eventually, only fragments of the linker 
were detected by MALDI. This might be the reason why there were mass peaks at 6092 Da 
and 6105 Da which correlate with the mass of the linker that lost a CH2 (6092) or the 
complete linker (6105). 
 
5. Conclusion 
The metallozyme based on an engineered hydrophobic channel-like membrane protein of 
E. coli (FhuA Δ1-159_C556_tev) and a ruthenium based metal catalyst ([Ru-Cp*]) was 
successfully developed. The coupling of the metal complex to C556 could be verified by 
cysteine titration as well as MALDI-TOF-MS. According to the cysteine titration, highest 
coupling efficiency was obtained by using no or 0.5 vol% THF for coupling. Structural 
integrity of FhuA Δ1-159_C556_tev was verified by CD spectrophotometer; no spectral 
differences of the distinct samples were observed.  
The metallozyme was designed towards Lewis acid activity which should allow to perform 
Diels-Alder (or Alder ene) reaction. The preliminary works in hybrid catalyst synthesis were 
successfully completed and the next follow-up work will include analysis of catalytic 
performances.    
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5 SUMMARY AND PROGRESS IN THE FIELD OF RESEARCH 
This work described the development of a metallozyme based on an engineered membrane 
protein of E. coli. The channel protein FhuA Δ1-159_C556_tev was used as the biomolecular 
scaffold and [Ru-Cp*] as the catalytic moiety. The metal catalyst was covalently bound to 
FhuA Δ1-159_C556_tev.   
FhuA variants were designed and generated by rational design or ordering a synthetic gene. 
The expression conditions for the different variants were optimized in terms of media 
composition, temperature and time. FhuA, FhuA Δ1-159, FhuA Δ1-159_C556 as well as FhuA 
Δ1-159_C556_tev were expressed in large scale (10 L). For the standard extraction, the 
efficiency of different detergents (oPOE, DM, DDM, HEOS or Fc-12) was compared. However, 
none of the detergents was applicable for all FhuA variants. Different organic solvents 
(2-MeTHF, C/M, CPME, TFE/C) were investigated to dissolve the lipid membranes and to 
precipitate FhuA variants. Denaturation of FhuA variants was performed using urea. Dialysis 
with PE-PEG enabled the refolding of FhuA variants to its natural conformation. The 
performance of a n-hexane-EtOH-SDS mixture was superior to all previously mentioned 
organic solvent extraction methods, yielding around 3.5-4 mg/mL FhuA Δ1-159 and FhuA 
Δ1-159_C556_tev which is equal to 700-800 mg protein extracted from one liter culture 
broth. 
Low percentages of organic cosolvent might be necessary to be supplemented in order to 
solubilize the organometallic species and/or the substrate. Therefore, CD 
spectrophotometry was carried out to investigate the structural integrity of FhuA and 
variants in presence of THF, EtOH, C/M and dioxane. FhuA wildtype and FhuA Δ1-159 were 
stable in up to 40 vol% THF and 10 vol% EtOH. In C/M mixtures, FhuA aggregated when there 
was more than 10 vol% of organic cosolvent present. FhuA Δ1-159 showed strong 
aggregation when 1 vol% C/M was added. FhuA Δ1-159_C556 indicated structural integrity 
in up to 25 vol% dioxane. pH stability studies of FhuA Δ1-159_C556_tev displayed that 
catalytic reactions in basic pH range (up to pH 10) are preferable over acidic pH values. 
Melting point determination by DSC showed that FhuA Δ1-159 (60.5 °C) is more stable than 
FhuA Δ1-159_C556_tev (54.6 °C).  
Synthesis and characterization of the maleimide linker as well as and the [Ru-Cp*] catalyst 
was carried out by cooperation partners, Prof. Okuda`s group (Institute for Inorganic 
Chemistry, RWTH Aachen University). MD simulation were performed to determine possible 
orientation of [Ru-Cp*] within the channel of FhuA Δ1-159_C556_tev. Coupling of the 
catalyst to the protein turned out to be best upon addition of no or 0.5 vol% THF using a 
molar ratio of FhuA Δ1-159_C556_tev:[Ru-Cp*] of 1:5. The coupling efficiency was verified 
by cysteine titration using ThioGlo1. In order to analyze the coupling with MALDI-TOF-MS, 
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FhuA Δ1-159_C556_tev-[Ru-Cp*] was digested with the tev-protease. Successful coupling of 
[Ru-Cp*] to FhuA Δ1-159_C556_tev was verified by MALDI-TOF-MS. Additionally, CD 
spectrophotometry was performed to analyze the structural integrity of the protein scaffold 
after coupling.  
This study established fundamentals within the scope of the use of a large, hydrophobic 
engineered membrane protein, FhuA Δ1-159_C556_tev, as a scaffold for metallozymes. To 
become attractive for applications in synthesis, several requirements must be met. First of 
all, the protein cavity has to be big enough to “engulf” the catalyst. To provide the best 
environment for the catalyst, the protein should be easily mutagenized without affecting the 
protein`s stability. Expression in large scale with low price is an essential. This comprises 
straight forward extraction with good yields and purity as well as stability of the protein host 
e.g. in organic cosolvents, at elevated temperatures and over a broad pH range. In fact, 
these requirements are met by FhuA. Nevertheless the costs and time for extraction still 
need to be reduced. In terms of catalysis, low catalyst loadings, catalyst recycling as well as 
high substrate concentration are crucial.   
In recent years, the field of metallozymes has turned from a “black-box” model to a more 
and more controlled system. Fundamental aspects in design and catalysis were investigated 
and first insights were gained in preparative scale application [1, 2]. Chemogenetic 
optimization is the key factor and most attractive feature to generate chemical and genetic 
diversity. Variation of the chemical moiety results in dramatic change in reactivity [11] while 
genetic engineering was observed to be mainly important for activity and selectivity of the 
system [12]. To set up a new hybrid system, it is advisable to have a look, if a protein with 
the desired mechanism is already available in nature. Adaption of this mechanism for 
specific requirements is much easier than de novo design of a metallozyme [4]. The main 
advantages regarding the synthetic aspects are the protein scaffold providing the chiral 
environment for catalysis and the catalytic performance in water. In future not only the 
design of novel metallozymes is of importance but the attempt to try to understand the 
effects and reaction mechanisms we see [150, 151]. Furthermore, applications in red and 
white biotechnology will be expanded e.g. the targeting of macromolecules such as DNA for 
cancer therapy [151] and the synthesis of specialized and expensive products [19].  
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11 APPENDIX 
11.1 Further projects  
11.1.1. Binding of Cecropin A-EGFP (CecEGFP) fusion protein on polypropylene (PP) fibres 
 
Tamara Dworeck, Stefanie-Joana Tenne, Noor Muhammad, Marco Fioroni and Ulrich 
Schwaneberg, Lehrstuhl für Biotechnologie, RWTH Aachen University. 
 
Cooperation with Christoph Hacker and Roy Dolmans, Lehrstuhl für Textilmaschinenbau und 
Institut für Textiltechnik (ITA), RWTH Aachen University.  
 
1. INTRODUCTION 
Cecropin A is an antimicrobial peptide, effective against Gram-positive and Gram-negative 
bacteria by assembling after insertion to ion pores and thereby destroying the ionic balance 
of cells. The peptide consists of 37 amino acids (KWKLFKKIEKVGQNIRDGIIK 
AGPAVAVVGQATQIAK-CONH2). To link EGFP to CecA, a linker consisting of 10 Alanin was 
introduced between the Cecropin A and EGFP (CecEGFP fusion system) (                                      
Figure 51a). Polypropylene (PP) (                                      Figure 51b) is a thermoplastic polymer, 
consisting of propylene monomers. It is used in a wide variety of applications; e.g. textiles 
and hernia meshes. PP has a melting point of 160 °C, an intermediate level of crystallinity 
between that of low density polyethylene and a high density polyethylene. The characteristic 
of this polymer is its toughness and at the same time flexibility.  
The concept of this project is the binding of the CecEGFP fusion system to the polymer 
polypropylene (PP). The binding will be based on the interaction of the hydrophobic part of 
the Cecropin with the surface of the polymer fibers. The binding can be confirmed by the 
detection of the EGFP-induced fluorescence, which is analyzed by fluorescence microscopy.   
Further steps can imply the introduction of a Cystein into the Cecropin peptide in order to 
crosslink individual PP fibers by disulfide bond formation.  
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Figure 51: a - Illustration of the fusion protein CecEGFP consisting of EGFP (yellow), a 10 Ala spacer 
(grey) and Cecropin A (violet). Fusion protein sketch is generated using Accelerys DS Visualizer 2.0. 
b - Projection formula of Polypropylene.  
 2. MATERIAL AND METHODS   
2.1 Expression of CecEGFP  
For pre-expression, one tooth pick of cells was taken and resuspended in 5 mL LBK medium 
(10 g/L peptone, 5 g/L yeast extract, 5 g/L NaCl, 50 µg/mL kanamycin). Incubation took place 
(test tube, 250 rpm, 8 h, 37 °C). The main-expression culture (1 L Erlenmeyer flask with 
200 mL autoinduction media (50 µg/mL kanamycin) was inoculated with 2 mL of pre-culture. 
The cultures were further incubated for 16-18 h. Expression of CecEGFP was checked under 
the UV-lamp. Cells were harvested by centrifugation (4000 rpm, 20 min, 4 °C, Eppendorf 54 
15 R). The remaining pellet was resuspended in lysis buffer (20 mM Tris, pH 8, 2.5 mM MgCl2, 
0.1 mM CaCl2, 1 mM EDTA, 1 mM PMSF, 0.025 mg/mL lysozyme) and incubated for 1.5 h at 
37 °C while gently shaking. Cell disruption was carried out by freeze-thawing (ON, -80 °C, RT) 
followed by centrifugation (18000 rpm, 25 min, 4 °C, Sorvall RC 6+ Thermo Scientific). The 
supernatant contained the CecEGFP fusion system (checked by SDS-PAGE and UV). The 
protein was further purified by passing through a pre-packed Ni-IDA column (14 mL, Ni-IDA 
Resin, Macherey-Nagel). Presence of CecEGFP was verified by SDS-PAGE. To get a higher 
protein concentration Amicon Ultra-4 Centrifugal Filter Units (30000 MWCO, Millipore) were 
used. The amount of protein was measured with the help of the BCA Protein Assay Kit 
(Thermo Scientific).  
 
 2.2 Binding of CecEGFP to PP  
3 cm long PP fibres were prepared by cutting the provided fibre (diameter 10 µm, Institut für 
Textiltechnik Aachen) into equal pieces. To roughen the PP surface, fibres were expanded by 
pulling apart the ends five times. To carry out the experiment, the following samples were 
prepared in glass vials:   
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a) PP + CecEGFP (100 µL, 1.5 mg/mL) in buffer   
b) PP + EGFP (50 µL, 0.9 mg/mL) + buffer* (50 µL)  
c) PP + buffer* (100 µL)  
* Phosphate buffer 0.1 M, pH 8 (K2HPO4, KH2PO4)  
After 15 min of stirring and incubation (Mot 3, RT, Ika Werke RT10), the PP fibers were taken 
out and put into glass vials containing only buffer (100 µL). The incubation-washing step was 
carried out once more. The so treated fibres were checked for fluorescence using the 
fluorescence microscope (excitation 405 nm, emission 508 nm, Filter 2, Orthoplan, Leitz).  
  
3. RESULTS AND DISCUSSION  
Fluorescence microscopic- and transmitted light images of the different samples are shown 
in Figure 52. 
 
Figure 52: Fluorescence (left panel) and transmitted light microscopy (right panel) pictures. a: PP + 
CecEGFP in buffer, b: PP + EGFP+ buffer, c: PP + buffer.  PP (polypropylene), CecEGFP (cecropinEGFP 
fusion protein). 
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The fibre treated with CecEGFP (Figure 52a, left) shows a clear bluish fluorescence while in 
case of fibres incubated with EGFP or neat buffer (Figure 52b and c), only a faint glow of the 
fibre surface was monitored. The previous experimental results clearly show that the CecA 
peptide is responsible for the interaction between the EGFP and the PP fibres. 
 
 
11.1.2. Circular dichroism stability investigations of recombinant β3-galactosidas C from Bacillus 
circulans  
 
Stefanie-Joana Tenne and Ulrich Schwaneberg, Lehrstuhl für Biotechnologie, RWTH Aachen 
University. 
 
Cooperation with Claudia Kamerke and Lothar Elling, Lehr- und Forschungsgebiet 
Biomaterialien, RWTH Aachen University.  
 
CD spectroscopy of differentially treated samples of β3-galactosidase C from B. circulans was 
performed and analyzed.  
Due to the novelty aspect of the obtained data and obligation of secrecy (data will be 
published in 2013), no results can be given.  
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11.2 Protocols (in alphabetical order) 
 Binding of CecropinEGFP to polypropylene (PP) 
 CD measurements of FhuA variants (in organic solvents) and deconvolution   
 Deconvolution via Dicroprot Programme 
 Dissolving and refolding of FhuA inclusion bodies, variant Δ1-159 
 Expression of FhuA and variants 
 Expression of FhuA Δ1-159_C556_tev 
 Extraction of FhuA and variants 
 Extraction of FhuA inclusion bodies, variant Δ1-159   
 Extrusion of liposomes (2.4.) 
 FhuA isolation with 2-MeTHF or CPME 
 FhuA Δ1-159_S556 isolation with TFE-chloroform 
 HRP-TMB assay (4.4.) 
 Liposome purification (3.4.) 
 n-hexane/ethanol/water extraction of  FhuA_Δ1-159_C556_tev, solubilization with 
SDS and refolding by dialysis 
 Preparation of competent E. coli omp8 
 Preparation of liposomes with incorporated FhuA- protein and HRP (Horse radish 
peroxidase) (1.4.) 
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11.3 Synthetic genes or sequencing results 
All strains and plasmids used in this dissertation were submitted to the strain/culture collection of 
the Schwaneberg Group (RWTH Aachen University). Synthetic gene- and sequencing information 
were also provided. 
 
11.4 List of chemicals and media 
Full name Abbreviation Formula Company Purity 
Ammonium chloride dihydrate  NH4Cl * 2 H2O Sigma  
Ampicilline  C16H18N3NaO4S AppliChem  
Boric acid  H3BO3 Fluka ≥99 % 
Calcium chloride  CaCl2 Fluka  99-103 % 
Carbamide Urea CH4N2O AppliChem ≥99.5 % 
Cobalt(II) chloride  CoCl2 
Riedel-de 
Haen 
 
Copper(II) chloride  CuCl2 Sigma ≥99 % 
Cyclopentyl- 
methyl-ether 
CPME C6H12O Sigma ≥99.9 % 
Dithiotreitol DTT C4H10O2S2 Sigma  
n-Decyl-β-D-maltoside DM  Applichem ≥99 % 
Di-sodium hydrogen 
phosphate 
 Na2HPO4 Applichem ≥99.5 % 
n-Dodecyl-β-D-maltoside DDM  Applichem 
f. molecular 
biology 
Ethanol  C2H6O Fluka 
f. molecular 
biology 
Ethylenediaminetetraacetic 
acid 
EDTA C10H14N2Na2O8 AppliChem 
Pure Ph. Eur. 
USP 
Fos-choline 12 Fc-12  Affimex >97 % 
Glucose monohydrate  C6H12O6 * 1 H2O Roth  
Glycerol  C3H8O3 Roth  
n-Hexane  C6H14 Merck ≥99 % 
2-Hydroxyethyloctylsulfoxide HEOS   ≥99 % 
Isopropyl-β-D-
thiogalactopyranosid 
IPTG C9H18O6S AppliChem  
Iron(III) chloride hexahydrate  FeCl3* 6 H2O Merck  
Magnesium sulfate 
heptahydrate 
 MgSO4  * 7 H2O Fluka  
Manganese(II) chloride  MnCl2 Fluka ≥99 % 
Methanol  CH4O Roth  
2-Methyl-tetrahydrofuran 2-MeTHF CH3C4H7O Sigma ≥99.5 % 
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4-Morpholine propanesulfonic 
acid 
MOPS C7H15NO4S Roth ≥99 % 
Magnesium chloride  MgCl2 Sigma ≥99.5 % 
Natriumchloride  NaCl Roth ≥99 % 
Natriumselenit pentahydrate  Na2SeO3* 4 H2O Omnilab Purum p.a. 
Nickel(II) chloride hexahydrate  NiCl2 * 6 H2O Sigma ≥99.5 % 
Octyl phenol ethoxylate Triton X-100 C33H60O10 Roth 
f. molecular 
biology 
Octyl polyoxyethylene oPOE 
CH3(CH2)7-O-(CH2-
CH2-O)XH 
Enzo life 
science 
Biochemical 
grade 
Pepton   AppliChem  
Phenylmethanesulfonyl 
fluoride 
PMSF C7H7FO2S AppliChem ≥99 % 
Poly(ethylene)- poly(ethylene-
glycol) 
PE-PEG C4H10O2 Aldrich  
Potassium hydrogen 
phosphate 
 K2HPO4 Rot ≥99 % 
Potassium salt  C2H3KO2 Sigma ≥99 % 
Rubidium chloride  RbCl2 Aldrich ≥99 % 
Sodium bicarbonate  Na2CO3 Fluka 99-103 % 
Sodiumcarbonate  NaHCO3 Sigma  
Sodium dodecyl sulphate SDS C12H25NaO4S Roth ≥99.5 % 
Sodium molybdate dihydrate  Na2MoO4 * 2 H2O Fluka  
Sodium sulfate  Na2SO4 Fluka ≥99 % 
3,3`5,5`-Tetramethylbenzidine TMB C16H20N2 Sigma For ELISA 
Trifluoroethanol TFE  Fluka Purum 
Trifluoromethane Chloroform CHCl3 Applichem ≥99 % 
Tris-hydrochlorid  Tris-HCl AppliChem ≥99 % 
Yeast Extract   AppliChem  
Zinc sulfate heptahydrate  ZnSo4 * 7 H2O Fluka ≥99 % 
     
 
Ampicilline (1000x stock)  100 mg/mL* 
*Final concentration is 100 µg/mL (Ampicilline should be sterilized by filtration (0.2 μm) and added 
after autoclaving to the medium). 
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LB-media 
Amount Component 
5 g Yeast extract 
10 g Tryptone 
10 g NaCl 
 
M9-media 
Amount Component 
16 g Na2HPO4
-*7H2O 
3.75 g KH2PO4 
0.625 g NaCl 
1.25 g NH4Cl 
0.24 g MgSO4 
44 g Glucose*H2O 
0.011 g CaCl2 
MgSO4, glucose and CaCl2 are sterilized by filtration and added to the autoclaved salts. 
 
SOB-media (pH 7) 
Amount Component 
5 g Yeast extract 
20 g Tryptone 
0.5 g NaCl 
0.186 g KCl 
2.4 g MgSO4 
For SOB+glc, add 4.4 g sterile glucose*H2O. 
 
SOC-media 
Amount Component 
5 g Yeast extract 
20 g Tryptone 
0.6 g NaCl 
0.2 g KCl 
2.03 g MgCl*6H2O 
2.47 g MgSO4*7H2O 
3.06 g Glucose*H2O 
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TYM505 
Amount Component 
5 g Yeast extract 
10 g Tryptone 
25 mM Na2HPO4 
25 mM KH2HPO4 
50 mM NH4SO4 
5 mM Na2SO4 
54 mM Glycerol 
2.8 mM Glucose 
2 mM MgSO4 
200 µL 1000x Trace elements 
(prepare 500 mL) 
 
Amount 1000x Trace elements 
50 mM FeCl3 
20 mM CaCl2 
10 mM MnCl2 
10 mM ZnSo4 
2 mM CoCl2 
2 mM CuCl2 
2 mM NiCl2 
2 mM Na2MoO4 
2 mM Na2SeO3 
2 mM H3BO3 
FeCl3 is dissolved in 250 mL 0.1 M HCl. 
TY-media 
Amount Component 
5 g Yeast extract 
10 g Tryptone 
5 g NaCl 
 
General remark: Tryptone (Applichem) gave best results. 
 
  
 
 
